Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	PAG1 SYNPO2 NAB1 NAB2 DHX9 NEFH ARID1B SQSTM1 TACC1 WWC1 MRTFA PML ZDHHC11B ATN1 TCOF1 TSNARE1 SORBS1 MED1 CBFA2T3 PIAS4 ANKRD13A SHANK2 ATF7IP ZNF451 EPC1 NCOA7 AKAP13 ZDHHC11	6.83e-05	1160	218	28	GO:0030674
GeneOntologyMolecularFunction	molecular adaptor activity	PAG1 SYNPO2 NAB1 NAB2 ECSIT DHX9 NEFH ARID1B SQSTM1 PKP2 TACC1 WWC1 MRTFA PML ZDHHC11B ATN1 TCOF1 TSNARE1 SORBS1 MED1 CBFA2T3 PIAS4 ANKRD13A SHANK2 ATF7IP ZNF451 EPC1 NCOA7 AKAP13 ZDHHC11 PCNT	7.43e-05	1356	218	31	GO:0060090
GeneOntologyMolecularFunction	signaling adaptor activity	PAG1 SQSTM1 WWC1 ZDHHC11B SORBS1 SHANK2 AKAP13 ZDHHC11	8.73e-05	129	218	8	GO:0035591
GeneOntologyMolecularFunction	transcription coregulator activity	NAB1 NAB2 DHX9 ARID1B SQSTM1 TACC1 WWC1 MRTFA PML ATN1 MED1 CBFA2T3 PIAS4 ATF7IP ZNF451 NCOA7	4.74e-04	562	218	16	GO:0003712
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	PSD MYO9A TSC2 CHM ARHGEF17 ARHGAP21 PSD2 ARHGEF18 ARHGAP9 ECT2 RGS12 DENND4C TBC1D10A AKAP13 ACAP2	4.78e-04	507	218	15	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	PSD MYO9A TSC2 CHM ARHGEF17 ARHGAP21 PSD2 ARHGEF18 ARHGAP9 ECT2 RGS12 DENND4C TBC1D10A AKAP13 ACAP2	4.78e-04	507	218	15	GO:0030695
GeneOntologyBiologicalProcess	intracellular transport	ACD FAM91A1 TSC2 CHM KCNIP3 LYST CHMP2A PLEKHM1 DHX9 NEFH C17orf75 TECPR2 SQSTM1 GLI3 TACC1 EEA1 ARHGAP21 WWC1 PML DRD1 TSNARE1 GRAMD1A FERMT1 NUMA1 POM121L2 MED1 PEX5L ECT2 EPG5 MICALL1 VPS13D TBC1D10A TRAPPC10 AKAP13 ACAP2 GGA1 PCNT	1.49e-06	1496	221	37	GO:0046907
GeneOntologyBiologicalProcess	regulation of small GTPase mediated signal transduction	PSD MYO9A TSC2 ARHGEF17 MET SQSTM1 MAP4K4 ARHGAP21 PSD2 ARHGEF18 ARHGAP9 ECT2 DENND4C ROBO1 AKAP13	3.32e-06	333	221	15	GO:0051056
GeneOntologyBiologicalProcess	neuron projection development	PSD MYO9A TSC2 NREP RNF157 HOXA2 NEFH MET NEO1 ARID1B BRAF PTPRZ1 USH1G GORASP1 GLI3 ANAPC2 PCDH15 MINAR1 MAP4K4 SLC23A2 MRTFA ROBO4 HSPG2 FN1 PPP1R9A NCKIPSD MICALL1 ZNF335 ENAH MACF1 ROBO1 NEUROG3	7.29e-06	1285	221	32	GO:0031175
GeneOntologyBiologicalProcess	cell morphogenesis	MYO9A TSC2 RNF157 HOXA2 NEFH MET NEO1 BRAF PTPRZ1 GORASP1 GLI3 NBEAL2 ANAPC2 PCDH15 MAP4K4 SLC23A2 ROBO4 HSPG2 FN1 FOSL2 PPP1R9A ARHGEF18 MED1 ECT2 ZNF335 ENAH MACF1 ROBO1 PRDM14 NEUROG3	1.23e-05	1194	221	30	GO:0000902
GeneOntologyBiologicalProcess	neuron development	PSD MYO9A TSC2 NREP RNF157 HOXA2 NEFH MET NEO1 ARID1B BRAF PTPRZ1 USH1G GORASP1 GLI3 ANAPC2 PCDH15 MINAR1 MAP4K4 SLC23A2 MRTFA ROBO4 HSPG2 DRD1 FN1 PPP1R9A NCKIPSD MICALL1 ZNF335 ENAH MACF1 ROBO1 CTF1 NEUROG3	1.58e-05	1463	221	34	GO:0048666
GeneOntologyBiologicalProcess	neuron projection morphogenesis	MYO9A TSC2 RNF157 HOXA2 NEFH MET NEO1 BRAF PTPRZ1 GORASP1 GLI3 ANAPC2 MAP4K4 SLC23A2 ROBO4 HSPG2 FN1 PPP1R9A ZNF335 ENAH MACF1 ROBO1 NEUROG3	1.83e-05	802	221	23	GO:0048812
GeneOntologyBiologicalProcess	negative regulation of transcription by RNA polymerase II	SP2 MAGEA10 KCNIP3 HOXA2 MET SETDB1 SALL1 SQSTM1 GLI3 WWC1 TBX22 TFEC ATN1 MED1 CBFA2T3 E2F8 PIAS4 BCL6B ZBED6 ATF7IP ZNF451 EPC1 ELK3 PAX3 MAPK10 PRDM14 NEUROG3	2.44e-05	1053	221	27	GO:0000122
GeneOntologyBiologicalProcess	plasma membrane bounded cell projection morphogenesis	MYO9A TSC2 RNF157 HOXA2 NEFH MET NEO1 BRAF PTPRZ1 GORASP1 GLI3 ANAPC2 MAP4K4 SLC23A2 ROBO4 HSPG2 FN1 PPP1R9A ZNF335 ENAH MACF1 ROBO1 NEUROG3	2.54e-05	819	221	23	GO:0120039
GeneOntologyBiologicalProcess	cell projection morphogenesis	MYO9A TSC2 RNF157 HOXA2 NEFH MET NEO1 BRAF PTPRZ1 GORASP1 GLI3 ANAPC2 MAP4K4 SLC23A2 ROBO4 HSPG2 FN1 PPP1R9A ZNF335 ENAH MACF1 ROBO1 NEUROG3	2.90e-05	826	221	23	GO:0048858
GeneOntologyBiologicalProcess	fibroblast proliferation	SP2 TSC2 DHX9 PTPRZ1 KMT2A PML FN1 FOSL2 E2F8	5.88e-05	160	221	9	GO:0048144
GeneOntologyBiologicalProcess	mammary gland morphogenesis	GLI3 PML MED1 ROBO1 PAX3 RXFP1	6.89e-05	65	221	6	GO:0060443
GeneOntologyBiologicalProcess	lung connective tissue development	FOSL2 RXFP1	1.14e-04	2	221	2	GO:0060427
GeneOntologyBiologicalProcess	positive regulation of neurogenesis	MET TTBK1 BRAF SYNJ1 PTPRZ1 ACAN GLI3 ANAPC2 WDR62 FN1 ZNF335 MACF1 ROBO1	1.23e-04	354	221	13	GO:0050769
GeneOntologyBiologicalProcess	intracellular protein transport	ACD FAM91A1 TSC2 CHM KCNIP3 C17orf75 TECPR2 SQSTM1 GLI3 PML DRD1 TSNARE1 FERMT1 POM121L2 MED1 PEX5L ECT2 VPS13D GGA1 PCNT	1.47e-04	740	221	20	GO:0006886
Domain	SEA	TMPRSS11D HSPG2 MUC16 MUC12 MUC13	4.53e-06	22	217	5	PF01390
Domain	SEA	TMPRSS11D HSPG2 MUC16 MUC12 MUC13	5.74e-06	23	217	5	PS50024
Domain	SEA_dom	TMPRSS11D HSPG2 MUC16 MUC12 MUC13	5.74e-06	23	217	5	IPR000082
Domain	-	MAGI1 SYNPO2 FRMPD4 GORASP1 ARHGAP21 PPP1R9A RGS12 RADIL SHANK2 PDZD2	1.04e-05	150	217	10	2.30.42.10
Domain	PH_dom-like	FRMPD4 PSD ARHGEF17 LYST PLEKHM1 NBEAL2 ARHGAP21 PSD2 FERMT1 ARHGEF18 ARHGAP9 ECT2 RGS12 MTMR7 ENAH AKAP13 ACAP2	1.07e-05	426	217	17	IPR011993
Domain	PDZ	MAGI1 SYNPO2 FRMPD4 GORASP1 ARHGAP21 PPP1R9A RGS12 RADIL SHANK2 PDZD2	1.10e-05	151	217	10	PS50106
Domain	PDZ	MAGI1 SYNPO2 FRMPD4 GORASP1 ARHGAP21 PPP1R9A RGS12 RADIL SHANK2 PDZD2	1.16e-05	152	217	10	IPR001478
Domain	SEA	TMPRSS11D HSPG2 MUC16 MUC13	1.62e-05	14	217	4	SM00200
Domain	FN3	SPEG CMYA5 NEO1 PTPRZ1 ROBO4 LRIT2 COL12A1 FN1 ATF7IP ROBO1 OSMR	2.20e-05	199	217	11	PS50853
Domain	FN3_dom	SPEG CMYA5 NEO1 PTPRZ1 ROBO4 LRIT2 COL12A1 FN1 ATF7IP ROBO1 OSMR	3.46e-05	209	217	11	IPR003961
Domain	PDZ	MAGI1 SYNPO2 FRMPD4 ARHGAP21 PPP1R9A RGS12 RADIL SHANK2 PDZD2	4.06e-05	141	217	9	PF00595
Domain	PDZ	MAGI1 SYNPO2 FRMPD4 ARHGAP21 PPP1R9A RGS12 RADIL SHANK2 PDZD2	5.93e-05	148	217	9	SM00228
Domain	FN3	SPEG CMYA5 NEO1 PTPRZ1 ROBO4 LRIT2 COL12A1 FN1 ROBO1 OSMR	6.29e-05	185	217	10	SM00060
Domain	fn3	SPEG CMYA5 NEO1 PTPRZ1 ROBO4 COL12A1 FN1 ROBO1 OSMR	1.19e-04	162	217	9	PF00041
Domain	Nab_N	NAB1 NAB2	1.34e-04	2	217	2	PD342192
Domain	NAB_co-repressor_dom	NAB1 NAB2	1.34e-04	2	217	2	IPR006989
Domain	Nab_N	NAB1 NAB2	1.34e-04	2	217	2	IPR006988
Domain	NCD2	NAB1 NAB2	1.34e-04	2	217	2	PF04905
Domain	NCD1	NAB1 NAB2	1.34e-04	2	217	2	PF04904
Domain	-	PSD ARHGEF17 PLEKHM1 ARHGAP21 PSD2 FERMT1 ARHGEF18 ARHGAP9 ECT2 RGS12 MTMR7 ENAH AKAP13 ACAP2	2.03e-04	391	217	14	2.30.29.30
Domain	REJ	PKD1L1 PKDREJ	7.94e-04	4	217	2	PS51111
Domain	REJ_dom	PKD1L1 PKDREJ	7.94e-04	4	217	2	IPR014010
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	MAGI1 ACACA MYO9A CCDC18 TSC2 ITPRID2 ARHGEF17 LYST CEP350 BRAF SYNJ1 SQSTM1 SVIL PKP2 KMT2A NHS MAP4K4 ARHGAP21 WDR62 PML CARMIL1 NCKIPSD FAM117B SORBS1 RFX7 ECT2 RGS12 DENND4C E2F8 MICALL1 KIAA1671 RADIL VPS13D NCOA7 MACF1 AKAP13 CRYBG3	7.16e-20	861	225	37	36931259
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	FRMPD4 SPEG FAM91A1 ARHGEF17 SNX19 RNF157 FOCAD NEFH SETDB1 SLC23A2 ARHGAP21 FKBP15 FRAS1 PPP1R9A SORBS1 AHCYL2 EPG5 ZNF451 MACF1 SENP7 PCNT PDZD2	3.55e-14	407	225	22	12693553
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	ACACA MYO9A KIAA0586 CEP350 SQSTM1 NHS ARHGAP21 WWC1 WDR62 DENND4C KIAA1671 VPS13D MACF1 ROBO1 CRYBG3	8.72e-12	209	225	15	36779422
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	ACACA FAM91A1 ITPRID2 DHX9 UBN1 BRAF SVIL KMT2A MAP4K4 MRTFA WDR62 ATN1 TCOF1 FOSL2 CARMIL1 NUMA1 MED1 WRAP53 RFX7 MICALL1 ZNF335 ZFP91 TRAPPC10 ELK3	2.93e-10	774	225	24	15302935
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ACACA SPEG TSC2 ZNF236 LYST PLEKHM1 FOCAD UBN1 SYNJ1 NBEAL2 ARHGAP21 HSPG2 FRAS1 FOSL2 TSNARE1 TWNK WRAP53 MICALL1 PIAS4 RADIL THADA AATK SHANK2 ZNF335 AKAP13 ZFYVE26 GGA1 PCNT	8.56e-10	1105	225	28	35748872
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	MAGI1 RUNDC3B TSC2 ARID1B BRAF PKP2 MAP4K4 WWC1 WDR62 FKBP15 PKP4 PPP1R9A NCKIPSD SORBS1 DENND4C KIAA1671 RADIL TRAPPC10	9.35e-10	446	225	18	24255178
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	MAGI1 PAG1 FAM91A1 ITPRID2 SYNJ1 SVIL PKP2 NHS ARHGAP21 CARMIL1 PKP4 FERMT1 SORBS1 DENND4C MICALL1 KIAA1671 SHANK2 TBC1D10A MACF1	6.27e-09	565	225	19	25468996
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	ACACA FAM91A1 DHX9 CEP350 MET NEO1 SQSTM1 GLI3 PKP2 TACC1 FAM135A ARHGAP21 FN1 TCOF1 FERMT1 MUC16 KIAA1671 THADA ZBED6 ATF7IP ROBO1 GGA1	8.74e-09	777	225	22	35844135
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	MYO9A ITPRID2 SETDB1 SALL1 UBN1 SYNJ1 SQSTM1 HSF2 FAM135A PML TCOF1 SORBS1 KIAA1671 PIAS4 ATF7IP ZNF451 MACF1 CRYBG3 PCNT	1.19e-08	588	225	19	38580884
Pubmed	Functional proteomics mapping of a human signaling pathway.	USP25 SETDB1 ARID1B GORASP1 ANAPC2 PKP2 HSPG2 FN1 TWNK ARHGAP9 EPG5 PIAS4 ANKRD13A ATF7IP ZNF451 PHACTR3 MACF1 ZBTB11 GGA1	1.29e-08	591	225	19	15231748
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SP2 KIAA0586 CEP350 FAT2 TTBK1 MINAR1 FAM135A PCDH18 PRUNE2 GRAMD1A ARHGEF18 ZFC3H1 RADIL VPS13D THADA MACF1 UNC80	2.82e-08	493	225	17	15368895
Pubmed	A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins.	FAM91A1 COQ3 ANAPC2 MAP4K4 SLC23A2 FAM135A ARHGAP21 PKP4 PPP1R9A MUC13 RGS12 DENND4C MICALL1 KIAA1671 THADA SHANK2 NCOA7 MACF1 ROBO1 ACAP2	5.71e-08	719	225	20	35337019
Pubmed	Host PDZ-containing proteins targeted by SARS-CoV-2.	MAGI1 FRMPD4 GORASP1 ARHGAP21 RADIL PDZD2	9.52e-08	35	225	6	33864728
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	NOL4 ACACA SETDB1 SALL1 SYNJ1 SQSTM1 ARHGAP21 MRTFA WDR62 DENND4C KIAA1671 ATF7IP CRYBG3 ZBTB11 PCNT	1.13e-07	418	225	15	34709266
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	MAGI1 DCAF8 ACACA MYO9A ZNF236 KCNIP3 LIN52 PLEKHM1 TECPR2 MARCHF1 PRUNE2 PTBP2 FOSL2 CARMIL1 TSNARE1 PPP1R9A ARHGEF18 FAM117B AHCYL2 KIAA1671 PIAS4 THADA SHANK2 ENAH MACF1 AKAP13 ELK3 PCNT PDZD2	1.35e-07	1489	225	29	28611215
Pubmed	A human MAP kinase interactome.	MAGI1 SYNPO2 MYO9A ITPRID2 CEP350 SETDB1 BRAF MAP4K4 SORBS1 MUC12 ATF7IP ZNF451 MACF1 ROBO1 AKAP13 MAPK10	1.37e-07	486	225	16	20936779
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	SYNPO2 ITPRID2 SALL1 UBN1 SQSTM1 MRTFA PRUNE2 ATN1 TCOF1 NUMA1 ARHGEF18 KIAA1671 AATK AKAP13 PCNT	1.63e-07	430	225	15	35044719
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	DCHS2 ACACA SPEG NBEAL2 KMT2A MAP4K4 ARHGAP21 FN1 CDKN2AIP CARMIL1 NUMA1 CCDC187 SORBS1 RGS12 VPS13D HYDIN	1.85e-07	497	225	16	36774506
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	MAGI1 MET NEO1 BRAF NBEAL2 PKP2 MAP4K4 FAM135A PCDH18 ARHGAP21 CARMIL1 PKP4 PPP1R9A FERMT1 RGS12 MICALL1 TBC1D10A	2.17e-07	569	225	17	30639242
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	NOL4 DCAF8 PSD CHMP2A SETDB1 ARID1B SQSTM1 GLI3 PKP2 WWC1 WDR62 PML ATN1 TCOF1 PKP4 KIAA1671 THADA EPC1 ZFP91 MACF1 CRYBG3 OSMR UNC80 SENP7	3.09e-07	1116	225	24	31753913
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	DCAF8 ACD FAM91A1 CHMP2A CEP350 SETDB1 SQSTM1 GORASP1 TSTD2 MAP4K4 ARHGAP21 WWC1 MRTFA FKBP15 TCOF1 CDKN2AIP FERMT1 NCKIPSD AHCYL2 DENND4C ANKRD13A SHANK2 ENAH	3.30e-07	1038	225	23	26673895
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	DCAF8 CCDC18 ITPRID2 ECSIT SNX19 DHX9 MET NEO1 TACC1 MAP4K4 FAM135A WDR62 PML FRAS1 TCOF1 PKP4 GRAMD1A TWNK ZFC3H1 MICALL1 THADA ZNF451 MACF1 ROBO1 AKAP13 ELP2 CRYBG3 PCNT	4.45e-07	1487	225	28	33957083
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	SQSTM1 GLI3 SVIL NHS TACC1 MAP4K4 FAM135A ARHGAP21 KIAA1671 MACF1 CRYBG3	1.32e-06	263	225	11	34702444
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	MAGI1 TSC2 NEFH SYNJ1 SVIL MAP4K4 UNC79 ARHGAP21 FKBP15 TCOF1 PKP4 PPP1R9A NUMA1 ARHGEF18 SORBS1 PEX5L SHANK2 ATF7IP ENAH MACF1 PCNT	1.42e-06	963	225	21	28671696
Pubmed	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	DCHS2 ACD FSIP1 TSC2 NREP PKP2 PCDH18 KIF6 DRD1 PKP4 SORBS1 ECT2 DDIAS RADIL AATK SHANK2 ENAH OSMR PDZD2	1.72e-06	814	225	19	23251661
Pubmed	A census of human transcription factors: function, expression and evolution.	SP2 ZNF236 HOXA2 SALL1 GLI3 KMT2A HSF2 TBX22 TFEC FOXN4 FOSL2 POU3F4 RFX7 E2F8 BCL6B ZNF451 ZNF335 ELK3 PAX3 NEUROG3	2.20e-06	908	225	20	19274049
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	SYNJ1 CACNA1G MINAR1 SLC23A2 MRTFA PRUNE2 AATK MACF1 UNC80 PCNT	2.34e-06	225	225	10	12168954
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	ACACA SYNJ1 KMT2A TACC1 ARHGAP21 WDR62 PML FKBP15 TCOF1 CDKN2AIP CARMIL1 NUMA1 MED1 KIAA1671 TRAP1 ATF7IP ENAH NCOA7 MACF1 PCNT	3.35e-06	934	225	20	33916271
Pubmed	Interaction network of human early embryonic transcription factors.	NOL4 NAB1 NAB2 LIN52 ARID1B SALL1 KMT2A ATN1 RFX7 KIAA1671 PIAS4 EPC1	3.54e-06	351	225	12	38297188
Pubmed	Over-expression of the chondroitin sulphate proteoglycan versican is associated with defective neural crest migration in the Pax3 mutant mouse (splotch).	ACAN HSPG2 PAX3	5.27e-06	6	225	3	9486530
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	FRMPD4 ARHGEF17 PLEKHM1 TECPR2 PRUNE2 ZFYVE26 PDZD2	5.39e-06	104	225	7	9205841
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	MAGI1 TSC2 ECSIT DHX9 SETDB1 USH1G GLI3 EEA1 WDR62 FKBP15 CARMIL1 FAM117B MED1 ECT2 DENND4C MICALL1 KIAA1671 ANKRD13A TRAP1 THADA ENAH TRAPPC10 ACAP2 GGA1	5.75e-06	1321	225	24	27173435
Pubmed	The nuclear interactome of DYRK1A reveals a functional role in DNA damage repair.	TSC2 ANAPC2 WDR62 FN1 FAM117B RFX7 ELP2	6.12e-06	106	225	7	31024071
Pubmed	p62/SQSTM1 Fuels Melanoma Progression by Opposing mRNA Decay of a Selective Set of Pro-metastatic Factors.	MAGI1 CEP350 BRAF SQSTM1 FN1 ARHGEF18 ROBO1 PCNT	9.93e-06	159	225	8	30581152
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	DCHS2 DCAF8 USP25 TSC2 CMYA5 CEP350 FOCAD SETDB1 SYNJ1 MAP4K4 UAP1L1 ARHGAP21 FN1 TCOF1 SORBS1 ZFC3H1 WRAP53 DALRD3 ZNF451 MACF1 ROBO1 ZBTB11 PCNT	1.15e-05	1285	225	23	35914814
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	ACACA PKD1L1 FAM91A1 CEP350 SYNJ1 SVIL MAP4K4 ARHGAP21 WDR62 CARMIL1 PKP4 SORBS1 RGS12 MICALL1 KIAA1671 ENAH GGA1 PCNT	1.28e-05	853	225	18	28718761
Pubmed	TBC1D23 is a bridging factor for endosomal vesicle capture by golgins at the trans-Golgi.	FAM91A1 C17orf75 FKBP15	1.46e-05	8	225	3	29084197
Pubmed	HGF-MET signals via the MLL-ETS2 complex in hepatocellular carcinoma.	MET KMT2A PAX3	1.46e-05	8	225	3	23934123
Pubmed	Robo4 is a vascular-specific receptor that inhibits endothelial migration.	ROBO4 ENAH ROBO1	1.46e-05	8	225	3	12941633
Pubmed	DYRK1A regulates the recruitment of 53BP1 to the sites of DNA damage in part through interaction with RNF169.	TSC2 ARHGEF17 LIN52 TCOF1 FAM117B RFX7 ENAH	1.54e-05	122	225	7	30773093
Pubmed	Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.	UFSP2 ACACA LYST ATN1 PCDHGA11 CARMIL1 AGGF1 MUC16 SHANK2 CLCA2 ZNF335 EPC1 PRDM14 UNC80	1.67e-05	552	225	14	10737800
Pubmed	Systematic identification of cancer cell vulnerabilities to natural killer cell-mediated immune surveillance.	ACACA SYNJ1 SQSTM1 TACC1 HSF2 TCOF1 NUMA1 SORBS1 CBFA2T3	1.81e-05	226	225	9	31452512
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	CCDC18 FAM91A1 ITPRID2 SNX19 CEP350 ARID1B PTPRZ1 SVIL NHS CDKN2AIP PKP4 GRAMD1A PPP1R9A KIAA1671 MTMR7 ENAH ROBO1 ELP2 CRYBG3 PCNT	1.82e-05	1049	225	20	27880917
Pubmed	BRAF activates PAX3 to control muscle precursor cell migration during forelimb muscle development.	MET BRAF PAX3	2.18e-05	9	225	3	27906130
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	PAG1 ACACA MET NHS MAP4K4 FAM135A ARHGAP21 CARMIL1 PKP4 PPP1R9A MACF1 ROBO1	2.18e-05	421	225	12	36976175
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	DCAF8 LIN52 DHX9 CEP350 ARID1B SQSTM1 GORASP1 SVIL ANAPC2 ABCG2 EEA1 HSF2 WDR62 CDKN2AIP CARMIL1 NUMA1 AGGF1 WRAP53 ECT2 TRAP1 ZNF451	2.25e-05	1155	225	21	20360068
Pubmed	Endothelial Loss of ETS1 Impairs Coronary Vascular Development and Leads to Ventricular Non-Compaction.	ACAN ROBO4 FN1 PAX3	2.66e-05	27	225	4	35894043
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	BRAF SQSTM1 ANAPC2 NHS MRTFA TCOF1 NUMA1 MED1 ECT2 DENND4C EPC1 ENAH AKAP13	2.76e-05	503	225	13	16964243
Pubmed	C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.	RUNDC3B TSC2 CHM LYST SNX19 PLEKHM1 NEO1 TACC1 FAM135A FKBP15 GRAMD1A DENND4C VPS13D	2.81e-05	504	225	13	34432599
Pubmed	New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.	MAGEA10 FRMPD4 DHX9 NEFH ACAN PML FRAS1 COL5A3 E2F8 TRAP1 OSMR LRRC37B ALPK2	3.38e-05	513	225	13	25798074
Pubmed	Charting the landscape of tandem BRCT domain-mediated protein interactions.	UFSP2 ITPRID2 CEP350 ANAPC2 MAP4K4 GPANK1 PML TCOF1 CDKN2AIP PKP4 NUMA1 AGGF1 ECT2 DALRD3 PCNT	3.53e-05	670	225	15	22990118
Pubmed	The transcriptional activator PAX3-FKHR rescues the defects of Pax3 mutant mice but induces a myogenic gain-of-function phenotype with ligand-independent activation of Met signaling in vivo.	MET PAX3	4.17e-05	2	225	2	14665670
Pubmed	TRAP1 is involved in BRAF regulation and downstream attenuation of ERK phosphorylation and cell-cycle progression: a novel target for BRAF-mutated colorectal tumors.	BRAF TRAP1	4.17e-05	2	225	2	25239454
Pubmed	Lower serum CA125 level, negative vascular invasion, and wild BRAF were strongly associated with better 2-year disease-free survival in patients with stage III colorectal cancer who received adjuvant chemotherapy.	BRAF MUC16	4.17e-05	2	225	2	29562502
Pubmed	Nuclear Localization of Robo is Associated with Better Survival in Bladder Cancer.	ROBO4 ROBO1	4.17e-05	2	225	2	30019121
Pubmed	Dual functions of histone-lysine N-methyltransferase Setdb1 protein at promyelocytic leukemia-nuclear body (PML-NB): maintaining PML-NB structure and regulating the expression of its associated genes.	SETDB1 PML	4.17e-05	2	225	2	21921037
Pubmed	PML Nuclear Bodies Are Altered in Adult-Onset Neuronal Intranuclear Hyaline Inclusion Disease.	SQSTM1 PML	4.17e-05	2	225	2	28863453
Pubmed	Novel digenic inheritance of PCDH15 and USH1G underlies profound non-syndromic hearing impairment.	USH1G PCDH15	4.17e-05	2	225	2	30029624
Pubmed	Magic roundabout is a new member of the roundabout receptor family that is endothelial specific and expressed at sites of active angiogenesis.	ROBO4 ROBO1	4.17e-05	2	225	2	11944987
Pubmed	Novel mutants of NAB corepressors enhance activation by Egr transactivators.	NAB1 NAB2	4.17e-05	2	225	2	9774344
Pubmed	MET-Driven Resistance to Dual EGFR and BRAF Blockade May Be Overcome by Switching from EGFR to MET Inhibition in BRAF-Mutated Colorectal Cancer.	MET BRAF	4.17e-05	2	225	2	27325282
Pubmed	Testis-specific hnRNP is expressed in colorectal cancer cells and accelerates cell growth mediating ZDHHC11 mRNA stabilization.	ZDHHC11B ZDHHC11	4.17e-05	2	225	2	35384384
Pubmed	Enhanced expression and phosphorylation of the MET oncoprotein by glioma-specific PTPRZ1-MET fusions.	MET PTPRZ1	4.17e-05	2	225	2	25935522
Pubmed	Tumour exosomes from cells harbouring PTPRZ1-MET fusion contribute to a malignant phenotype and temozolomide chemoresistance in glioblastoma.	MET PTPRZ1	4.17e-05	2	225	2	28504721
Pubmed	Novel SH3 protein encoded by the AF3p21 gene is fused to the mixed lineage leukemia protein in a therapy-related leukemia with t(3;11) (p21;q23).	KMT2A NCKIPSD	4.17e-05	2	225	2	10648423
Pubmed	The transcriptional cofactor MCAF1/ATF7IP is involved in histone gene expression and cellular senescence.	PML ATF7IP	4.17e-05	2	225	2	23935871
Pubmed	ZDHHC11 and ZDHHC11B are critical novel components of the oncogenic MYC-miR-150-MYB network in Burkitt lymphoma.	ZDHHC11B ZDHHC11	4.17e-05	2	225	2	28331227
Pubmed	Targeting TRAP1 as a downstream effector of BRAF cytoprotective pathway: a novel strategy for human BRAF-driven colorectal carcinoma.	BRAF TRAP1	4.17e-05	2	225	2	26084290
Pubmed	Receptor-type protein tyrosine phosphatase beta (RPTP-beta) directly dephosphorylates and regulates hepatocyte growth factor receptor (HGFR/Met) function.	MET PTPRZ1	4.17e-05	2	225	2	21454675
Pubmed	Disruption of de novo fatty acid synthesis via acetyl-CoA carboxylase 1 inhibition prevents acute graft-versus-host disease.	ACACA TACC1	4.17e-05	2	225	2	27338930
Pubmed	Robo1/Robo4: differential expression of angiogenic markers in colorectal cancer.	ROBO4 ROBO1	4.17e-05	2	225	2	16685377
Pubmed	Outcome of lumbar epidural steroid injection is predicted by assay of a complex of fibronectin and aggrecan from epidural lavage.	ACAN FN1	4.17e-05	2	225	2	21224775
Pubmed	RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas.	MET PTPRZ1	4.17e-05	2	225	2	25135958
Pubmed	Nonsense-mediated decay and the molecular pathogenesis of mutations in SALL1 and GLI3.	SALL1 GLI3	4.17e-05	2	225	2	18000979
Pubmed	Differential deposition of basement membrane components during formation of the caudal neural tube in the mouse embryo.	HSPG2 FN1	4.17e-05	2	225	2	3665768
Pubmed	Search for mutations in the EGR2 corepressor proteins, NAB1 and NAB2, in human peripheral neuropathies.	NAB1 NAB2	4.17e-05	2	225	2	12030330
Pubmed	Neural tube defects in embryos of diabetic mice: role of the Pax-3 gene and apoptosis.	FN1 PAX3	4.17e-05	2	225	2	9200655
Pubmed	Reviving oncogenic addiction to MET bypassed by BRAF (G469A) mutation.	MET BRAF	4.17e-05	2	225	2	30224486
Pubmed	High-sensitive clinical diagnostic method for PTPRZ1-MET and the characteristic protein structure contributing to ligand-independent MET activation.	MET PTPRZ1	4.17e-05	2	225	2	33645009
Pubmed	Genetic deletion or tyrosine phosphatase inhibition of PTPRZ1 activates c-Met to up-regulate angiogenesis and lung adenocarcinoma growth.	MET PTPRZ1	4.17e-05	2	225	2	37260355
Pubmed	Overexpression of ATP-binding cassette transporter ABCG2 as a potential mechanism of acquired resistance to vemurafenib in BRAF(V600E) mutant cancer cells.	BRAF ABCG2	4.17e-05	2	225	2	23153455
Pubmed	Characterization of the Enzymatic Activity of SETDB1 and Its 1:1 Complex with ATF7IP.	SETDB1 ATF7IP	4.17e-05	2	225	2	26813693
Pubmed	Impact of MET expression on outcome in BRAF(V600E/K) advanced melanoma.	MET BRAF	4.17e-05	2	225	2	23802768
Pubmed	Ten years on: mediation of cell death by the common neurotrophin receptor p75(NTR).	ARHGEF17 SQSTM1 ARHGEF18 ECT2 AKAP13	4.43e-05	60	225	5	12787561
Pubmed	A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart.	SVIL FN1 PTBP2 SORBS1 ENAH	4.43e-05	60	225	5	19075228
Pubmed	Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization.	TSC2 BRAF SVIL PKP2 NCKIPSD RGS12 MICALL1 RADIL AKAP13	4.66e-05	255	225	9	15324660
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	MAGI1 DCAF8 CEP350 C17orf75 UBN1 SYNJ1 SVIL COL12A1 NCKIPSD AGGF1 ANKRD13A THADA ZNF451 ZNF335 AKAP13	4.84e-05	689	225	15	36543142
Pubmed	Global genetic analysis in mice unveils central role for cilia in congenital heart disease.	PKD1L1 ACAN WDR62 FRAS1 TRAPPC10 ROBO1	4.93e-05	100	225	6	25807483
Pubmed	Proximity interactions among centrosome components identify regulators of centriole duplication.	MYO9A KIAA0586 CEP350 SQSTM1 KIAA1671 PCNT	5.21e-05	101	225	6	24613305
Pubmed	Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer.	MAGI1 ARHGEF17 BRAF PKP2 ARHGAP21 FAM117B	5.50e-05	102	225	6	15778465
Pubmed	Kindlin-2 Is Essential for Preserving Integrity of the Developing Heart and Preventing Ventricular Rupture.	HSPG2 FN1 FERMT1	5.63e-05	12	225	3	30883226
Pubmed	Interrogating the protein interactomes of RAS isoforms identifies PIP5K1A as a KRAS-specific vulnerability.	PAG1 FAM91A1 NEO1 BRAF PKP2 TACC1 MAP4K4 SLC23A2 PKP4 TBC1D10A MACF1 ROBO1	5.94e-05	467	225	12	30194290
Pubmed	Human transcription factor protein interaction networks.	NOL4 SP2 SETDB1 ARID1B SALL1 UBN1 SQSTM1 GLI3 SVIL KMT2A PML HSPG2 ATN1 DNAH10 NUMA1 TWNK RFX7 KIAA1671 ATF7IP ZNF451 EPC1 ZFP91 ELK3	5.98e-05	1429	225	23	35140242
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	NOL4 SP2 DHX9 HOXA2 ARID1B SALL1 BRAF SYNJ1 NCKIPSD ATF7IP EPC1	6.33e-05	398	225	11	35016035
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	SP2 NAB1 NAB2 ZNF236 KCNIP3 HOXA2 GLI3 MRTFA PML POU3F4 MED1 E2F8 PIAS4 BCL6B ZNF451 PAX3 PRDM14	6.42e-05	877	225	17	20211142
Pubmed	Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	KIAA0586 NBEAL2 ARHGEF18 ZFC3H1 PCDHGA12 ZNF451	6.47e-05	105	225	6	9628581
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	MAGI1 MYO9A DHX9 PKP2 MAP4K4 FAM135A ARHGAP21 TCOF1 CARMIL1 NUMA1 DENND4C MICALL1 MACF1 ROBO1 CRYBG3	6.56e-05	708	225	15	39231216
Pubmed	Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.	SPEG ANAPC2 UNC79 FAM135A ARHGAP21 MRTFA SORBS1	6.58e-05	153	225	7	10718198
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	UBN1 SVIL TACC1 FOSL2 NUMA1 DALRD3 TRAP1 ZBED6 MACF1 ALPK2	6.73e-05	332	225	10	37433992
Pubmed	Ontogenesis of the tear drainage system requires Prickle1-driven polarized basement membrane deposition.	GORASP1 HSPG2 FN1	7.28e-05	13	225	3	33144400
Interaction	YWHAH interactions	MAGI1 MYO9A SPEG CCDC18 TSC2 ITPRID2 ARHGEF17 LYST CEP350 BRAF SYNJ1 SQSTM1 SVIL PKP2 KMT2A NHS MAP4K4 ARHGAP21 WWC1 WDR62 FN1 CARMIL1 NCKIPSD TWNK FAM117B SORBS1 MED1 RFX7 ECT2 RGS12 DENND4C E2F8 MICALL1 KIAA1671 RADIL VPS13D TRAPPC10 NCOA7 MACF1 AKAP13 CRYBG3 PCNT	7.09e-13	1102	218	42	int:YWHAH
Interaction	YWHAB interactions	MAGI1 MYO9A SPEG CCDC18 TSC2 ITPRID2 ARHGEF17 LYST DHX9 CEP350 BRAF SQSTM1 SVIL PKP2 KMT2A NHS ARHGAP21 WWC1 WDR62 FN1 NCKIPSD FAM117B SORBS1 RFX7 ECT2 RGS12 DENND4C E2F8 MICALL1 KIAA1671 RADIL VPS13D TRAPPC10 MACF1 AKAP13	1.10e-09	1014	218	35	int:YWHAB
Interaction	SFN interactions	MAGI1 MYO9A CCDC18 TSC2 ITPRID2 ARHGEF17 LYST CEP350 MET BRAF SQSTM1 SVIL PKP2 KMT2A NHS EEA1 MAP4K4 ARHGAP21 WDR62 CARMIL1 FAM117B SORBS1 RGS12 DENND4C KIAA1671 MACF1 AKAP13 CRYBG3	2.01e-09	692	218	28	int:SFN
Interaction	YWHAG interactions	MAGI1 SYNPO2 MYO9A SPEG CCDC18 TSC2 ITPRID2 ARHGEF17 LYST CEP350 TTBK1 BRAF SYNJ1 SQSTM1 SVIL PKP2 KMT2A NHS MAP4K4 ARHGAP21 WWC1 WDR62 FN1 CARMIL1 NCKIPSD FAM117B SORBS1 RFX7 RGS12 DENND4C E2F8 MICALL1 KIAA1671 RADIL VPS13D TRAPPC10 MACF1 AKAP13	6.21e-09	1248	218	38	int:YWHAG
Interaction	ZYX interactions	KIAA0586 CEP350 SVIL FAM135A ARHGAP21 MRTFA PML FKBP15 FN1 ARHGAP9 SORBS1 KIAA1671 ENAH MACF1 AKAP13 CRYBG3 PCNT	1.19e-07	329	218	17	int:ZYX
Interaction	YWHAQ interactions	ACACA MYO9A SPEG CCDC18 TSC2 ITPRID2 LYST DHX9 CEP350 BRAF SVIL PKP2 KMT2A NHS UNC79 ARHGAP21 WWC1 WDR62 FN1 NCKIPSD NUMA1 FAM117B SORBS1 MED1 RFX7 RGS12 DENND4C E2F8 KIAA1671 VPS13D MACF1 AKAP13	4.60e-07	1118	218	32	int:YWHAQ
Interaction	YWHAZ interactions	SYNPO2 MYO9A SPEG CCDC18 TSC2 ITPRID2 LYST BRAF SQSTM1 NBEAL2 SVIL PKP2 KMT2A NHS ARHGAP21 WDR62 PML FN1 NCKIPSD ARHGEF18 FAM117B SORBS1 ECT2 RGS12 DENND4C E2F8 MICALL1 KIAA1671 RADIL VPS13D ENAH MACF1 AKAP13 SENP7 PCNT	7.37e-07	1319	218	35	int:YWHAZ
Interaction	GSK3A interactions	DCAF8 ACACA MYO9A KIAA0586 CEP350 SQSTM1 GLI3 NHS ARHGAP21 WWC1 WDR62 PTBP2 RFX7 DENND4C KIAA1671 VPS13D MACF1 ROBO1 CRYBG3	7.70e-07	464	218	19	int:GSK3A
Interaction	PFN1 interactions	MYO9A CEP350 SYNJ1 SQSTM1 FAM135A ARHGAP21 MRTFA WDR62 FN1 CARMIL1 BIRC3 DENND4C KIAA1671 THADA ENAH MACF1 AKAP13 CRYBG3 PCNT	3.01e-06	509	218	19	int:PFN1
Interaction	VASP interactions	MAGI1 CEP350 SYNJ1 SQSTM1 SVIL NHS FAM135A ARHGAP21 MRTFA WDR62 FN1 SORBS1 KIAA1671 ENAH	4.16e-06	294	218	14	int:VASP
Interaction	RAB35 interactions	PAG1 FAM91A1 CHM PKP2 TACC1 MAP4K4 FAM135A ARHGAP21 FN1 CARMIL1 PKP4 GRAMD1A PPP1R9A AHCYL2 DENND4C MICALL1 NCOA7 MACF1 ROBO1 ACAP2	4.51e-06	573	218	20	int:RAB35
Interaction	STX6 interactions	FAM91A1 SYNJ1 TACC1 EEA1 MARCHF1 FAM135A ARHGAP21 FAM234B CARMIL1 PKP4 DENND4C MICALL1 TRAPPC10 NCOA7 MACF1 ROBO1 CRYBG3	8.21e-06	448	218	17	int:STX6
Interaction	RHOB interactions	MAGI1 PAG1 MYO9A FAM91A1 TSC2 NEO1 PKP2 MAP4K4 FAM135A ARHGAP21 CARMIL1 PKP4 PPP1R9A ARHGEF18 AHCYL2 MUC13 ECT2 MICALL1 ANKRD13A TBC1D10A NCOA7 MACF1 ROBO1 AKAP13	1.47e-05	840	218	24	int:RHOB
Interaction	PHF21A interactions	NOL4 ACACA SALL1 SYNJ1 SQSTM1 ARHGAP21 MRTFA WDR62 PML DENND4C KIAA1671 CRYBG3 ZBTB11 PCNT	2.37e-05	343	218	14	int:PHF21A
Interaction	GOLGA1 interactions	CCDC18 FAM91A1 CEP350 SQSTM1 DENND4C KIAA1671 NCOA7 MACF1 CRYBG3 PCNT	3.17e-05	183	218	10	int:GOLGA1
Interaction	EZR interactions	DCAF8 CCDC18 SYNJ1 SVIL FAM135A ARHGAP21 PML FN1 PPP1R9A BIRC3 SORBS1 AHCYL2 KIAA1671 TBC1D10A ENAH TRAPPC10 MACF1 MAPK10	3.46e-05	553	218	18	int:EZR
Interaction	YWHAE interactions	ACD MYO9A CCDC18 TSC2 ITPRID2 LYST DHX9 BRAF SQSTM1 SVIL PKP2 KMT2A NHS ARHGAP21 WWC1 WDR62 FN1 NCKIPSD BIRC3 FAM117B SORBS1 RGS12 DENND4C E2F8 MICALL1 KIAA1671 RADIL MACF1 AKAP13 ACAP2	3.76e-05	1256	218	30	int:YWHAE
Interaction	CAV1 interactions	MAGI1 PAG1 TSC2 MET NEO1 SQSTM1 PKP2 MAP4K4 FAM135A ARHGAP21 PML PKP4 PPP1R9A AHCYL2 ECT2 DENND4C MICALL1 ANKRD13A NCOA7 MACF1 ROBO1	4.16e-05	724	218	21	int:CAV1
Interaction	AP2B1 interactions	CCDC18 CEP350 BRAF SYNJ1 SQSTM1 GPANK1 FKBP15 FN1 CCDC187 PEX5L ECT2 KIAA1671 AATK PCNT	5.90e-05	373	218	14	int:AP2B1
Interaction	CAPZA2 interactions	ITPRID2 ARHGEF17 SQSTM1 SVIL ARHGAP21 CARMIL1 PKP4 PPP1R9A NCKIPSD NUMA1 BIRC3 ECT2 MICALL1 KIAA1671 MACF1	7.35e-05	430	218	15	int:CAPZA2
Interaction	CDH1 interactions	MAGI1 PAG1 FAM91A1 ITPRID2 MET SYNJ1 SVIL PKP2 NHS ARHGAP21 CARMIL1 PKP4 FERMT1 SORBS1 ECT2 DENND4C MICALL1 KIAA1671 SHANK2 TBC1D10A MACF1	9.61e-05	768	218	21	int:CDH1
Interaction	SYNE3 interactions	CCDC18 ITPRID2 SNX19 CEP350 SQSTM1 GLI3 PKP2 TACC1 ARHGAP21 GRAMD1A SORBS1 KIAA1671 MACF1 CRYBG3 PCNT	1.05e-04	444	218	15	int:SYNE3
Interaction	C2CD4B interactions	SVIL FRAS1 AGGF1 MACF1 ALPK2	1.09e-04	44	218	5	int:C2CD4B
Interaction	TOP3B interactions	ACACA SPEG TSC2 ZNF236 LYST PLEKHM1 DHX9 FOCAD UBN1 SYNJ1 NBEAL2 SVIL PKP2 ARHGAP21 HSPG2 FRAS1 FOSL2 TSNARE1 PPP1R9A TWNK WRAP53 MICALL1 PIAS4 RADIL THADA AATK SHANK2 ZNF335 AKAP13 ZFYVE26 GGA1 PCNT	1.18e-04	1470	218	32	int:TOP3B
Interaction	ATF7IP interactions	HOXA2 SETDB1 PML HSPG2 EPG5 PIAS4 ATF7IP MACF1	1.31e-04	138	218	8	int:ATF7IP
Interaction	AMOT interactions	MAGI1 CCDC18 CEP350 SQSTM1 MAP4K4 WWC1 WDR62 FKBP15 BIRC3 KIAA1671 CRYBG3 PCNT	1.59e-04	312	218	12	int:AMOT
GeneFamily	PDZ domain containing	MAGI1 SYNPO2 FRMPD4 GORASP1 ARHGAP21 PPP1R9A RGS12 RADIL SHANK2 PDZD2	8.05e-07	152	156	10	1220
GeneFamily	Fibronectin type III domain containing	CMYA5 NEO1 PTPRZ1 ROBO4 COL12A1 FN1 ATF7IP ROBO1 OSMR	1.05e-05	160	156	9	555
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	PSD PLEKHM1 ARHGAP21 PSD2 FERMT1 ARHGEF18 ARHGAP9 AKAP13 ACAP2	7.65e-05	206	156	9	682
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	TSC2 UBN1 WWC1 FKBP15 PPP1R9A AATK PHACTR3 HYDIN	1.78e-04	181	156	8	694
GeneFamily	Cadherin related	DCHS2 FAT2 PCDH15	3.92e-04	17	156	3	24
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	SPEG NEO1 ROBO4 HSPG2 LRIT2 ROBO1 ALPK2	5.00e-04	161	156	7	593
GeneFamily	CD molecules\|Mucins	MUC16 MUC12 MUC13	7.48e-04	21	156	3	648
GeneFamily	Zinc fingers MYND-type\|A-kinase anchoring proteins	CMYA5 CBFA2T3 AKAP13	1.95e-03	29	156	3	396
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	ARHGEF17 ARHGEF18 ECT2 AKAP13	2.54e-03	66	156	4	722
GeneFamily	WD repeat domain containing\|BEACH domain containing	LYST NBEAL2	2.56e-03	9	156	2	1230
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	NOL4 ABCA3 FRMPD4 PSD RUNDC3B SPEG TSC2 NREP LYST RNF157 FAT2 SYNJ1 CACNA1G EEA1 MARCHF1 UNC79 FKBP15 PSD2 PPP1R9A FAM117B SORBS1 RFX7 PEX5L AATK SHANK2 PHACTR3 NCOA7 ROBO1 HYDIN	8.64e-08	1106	224	29	M39071
Coexpression	DE_YY1_TARGETS_DN	MET TACC1 FN1 NUMA1 AGGF1 ECT2 MACF1 OSMR	1.37e-06	93	224	8	M3278
Coexpression	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3	CEP350 MET FAT2 SVIL PKP2 NHS ARHGAP21 WWC1 PML COL12A1 FOSL2 FERMT1 AGGF1 RGS12 MICALL1 THADA ZNF335 ENAH ZFP91 AKAP13 ELK3 LRRC37B	3.76e-06	843	224	22	M2356
Coexpression	GSE3920_UNTREATED_VS_IFNB_TREATED_ENDOTHELIAL_CELL_UP	SVIL TACC1 MAP4K4 MRTFA GRAMD1A MUC13 ECT2 ANKRD13A HYDIN PCNT	9.29e-06	200	224	10	M6686
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO9A CMYA5 LYST DHX9 CEP350 PCDH18 ARHGAP21 ECM2 ZBED6 ATF7IP MACF1	1.70e-09	176	225	11	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NOL4 FRMPD4 PCDH15 UNC79 FRAS1 COL12A1 DNAH10 PHACTR3 ROBO1 HYDIN UNC80	2.71e-09	184	225	11	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NOL4 FRMPD4 PCDH15 UNC79 FRAS1 COL12A1 DNAH10 PHACTR3 ROBO1 HYDIN UNC80	2.71e-09	184	225	11	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NOL4 FRMPD4 PCDH15 UNC79 FRAS1 COL12A1 DNAH10 PHACTR3 ROBO1 HYDIN UNC80	2.71e-09	184	225	11	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 ARID1B SVIL NHS FRAS1 AHCYL2 SHANK2 MACF1 AKAP13 MAPK10 PDZD2	4.24e-09	192	225	11	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 CMYA5 MET NHS FAM135A WWC1 PRUNE2 FRAS1 PPP1R9A SHANK2 MAPK10	4.73e-09	194	225	11	7002937e8903e037332a215d00fbc7c7843b33f2
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ITPRID2 NREP KMT2A FAM135A ROBO4 COL12A1 PKP4 PPP1R9A MACF1 ELK3 PCNT	6.49e-09	200	225	11	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A MET MARCHF1 WWC1 PRUNE2 FRAS1 COL12A1 RGS12 LIX1 PDZD2	3.07e-08	181	225	10	9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A MET MARCHF1 WWC1 PRUNE2 FRAS1 COL12A1 RGS12 LIX1 PDZD2	3.23e-08	182	225	10	eb138aa1dca9373f1586600f258df06dcf56d81f
ToppCell	droplet-Marrow-nan-3m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LYST DHX9 CEP350 MET EEA1 TFEC FN1 TCOF1 CBFA2T3 PKIB	3.23e-08	182	225	10	bc8d621be57f76d718d9b0f11e023b0f4dcb668d
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MAGI1 MET NBEAL2 FAM135A WWC1 HSPG2 COL12A1 ANKRD13A SHANK2 OSMR	4.39e-08	188	225	10	43a3a59f92ad93509d4166bd025aed0b1b39a008
ToppCell	Adult-Epithelial\|Adult / Lineage, Cell type, age group and donor	MAGI1 ABCA3 ACACA MET WWC1 PPP1R9A SHANK2 OSMR MAPK10 PDZD2	5.36e-08	192	225	10	efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 CMYA5 NHS WWC1 PRUNE2 FRAS1 PKP4 PPP1R9A SHANK2 MAPK10	5.63e-08	193	225	10	3866667dd221612589ae50f5c52f73a183a49ce6
ToppCell	nucseq-Epithelial-Epithelial_Alveolar\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MAGI1 ABCA3 ACACA MYO9A WWC1 PPP1R9A SHANK2 NCOA7 MAPK10 PDZD2	5.91e-08	194	225	10	53f3e49e91b1096f3226010e2de767efb490dfe4
ToppCell	nucseq-Epithelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MAGI1 ABCA3 ACACA MYO9A WWC1 PPP1R9A SHANK2 NCOA7 MAPK10 PDZD2	6.20e-08	195	225	10	9406866f99555198a9be311fbd65751b70f35446
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	MAGI1 ACACA MYO9A ARID1B BRAF PPP1R9A RFX7 SHANK2 MAPK10 PDZD2	6.50e-08	196	225	10	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A MET NHS WWC1 PRUNE2 FRAS1 PPP1R9A SHANK2 MAPK10 HYDIN	6.82e-08	197	225	10	7e93a97b5ac5ae2f77a4b3141082a1463fed00dd
ToppCell	Parenchymal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MAGI1 ABCA3 ACACA MYO9A MET WWC1 PPP1R9A SHANK2 MAPK10 PDZD2	7.50e-08	199	225	10	5cea0d9e261903e0eaad60c28a07dff72ce65027
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SALL1 PTPRZ1 SVIL PKP2 MARCHF1 ANO4 KIF6 SORBS1 PKIB	2.19e-07	170	225	9	14aa86a4f526ed6986afcb28c49225522055550c
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PAG1 SYNPO2 ACAN MINAR1 WDR62 COL12A1 FN1 E2F8 POLQ	2.30e-07	171	225	9	b0373ed8283ee1792b6a490bff93906546978593
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PAG1 SYNPO2 ACAN MINAR1 WDR62 COL12A1 FN1 E2F8 POLQ	2.30e-07	171	225	9	b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA3 ATP6AP1L HOXA2 PRUNE2 TFEC COL28A1 PPP1R9A ZBED6 ALPK2	2.93e-07	176	225	9	33323c97afe509147956b8df9f92ca6b0537e604
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SALL1 PTPRZ1 SVIL PCDH15 PKP2 ANO4 KIF6 SORBS1 PKIB	2.93e-07	176	225	9	05ec715439f2eb1696f5d8855da0dd1dd70effd0
ToppCell	COVID-19-kidney-Epi_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DCHS2 MYO9A MET NHS WWC1 PRUNE2 SHANK2 HYDIN ALPK2	3.23e-07	178	225	9	544379f5a6145429762258d426b876bb36c112f5
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MAGI1 ABCA3 ACACA MET FAM135A WWC1 TRAP1 SHANK2 OSMR	3.72e-07	181	225	9	576da14ab3107f89e1f44a4a439d1bef5bb42370
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MAGI1 ABCA3 ACACA MET WWC1 PPP1R9A SHANK2 MAPK10 PDZD2	4.08e-07	183	225	9	6847c1252d6bb105524f812658112517fd351eab
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NOL4 MYO9A MET MARCHF1 WWC1 PRUNE2 RGS12 HYDIN LIX1	4.08e-07	183	225	9	92fbd83a9d13ee91065cbd479fb298f1fd564568
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MAGI1 ACACA MET WWC1 COL28A1 PPP1R9A SHANK2 OSMR MAPK10	4.27e-07	184	225	9	102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A GLI3 NHS WWC1 PRUNE2 FRAS1 PKP4 HYDIN PDZD2	4.68e-07	186	225	9	f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	PAG1 ARID1B BRAF KMT2A EPG5 ZBED6 ATF7IP MACF1 ZBTB11	5.11e-07	188	225	9	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	Mesenchymal-myofibroblast_cell\|World / Lineage, Cell type, age group and donor	SYNPO2 NHS PCDH18 ANO4 COL12A1 FN1 ENAH ROBO1 UNC80	5.35e-07	189	225	9	44e37f88137bb249933eb615235b2cf2ae7f3925
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	MAGI1 SYNPO2 CMYA5 SVIL PKP2 SORBS1 AKAP13 ALPK2 PDZD2	5.35e-07	189	225	9	5e80c47f63980904c4c1ff02c201b67b456a0974
ToppCell	LA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	SYNPO2 NHS PRUNE2 FN1 CARMIL1 SORBS1 ENAH MACF1 PAX3	5.35e-07	189	225	9	6b3e88751b95fc2173f2c3d5061ed632d0c5f01c
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|RV / Chamber and Cluster_Paper	MAGI1 SYNPO2 CMYA5 SVIL PKP2 SORBS1 AKAP13 ALPK2 PDZD2	5.59e-07	190	225	9	fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MAGI1 ABCA3 ACACA MET WWC1 PPP1R9A SHANK2 MAPK10 PDZD2	5.84e-07	191	225	9	a0332a4ef629510fb313ec119195c44a3f704a80
ToppCell	Children_(3_yrs)-Epithelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MAGI1 ABCA3 ACACA MET WWC1 PPP1R9A SHANK2 MAPK10 PDZD2	5.84e-07	191	225	9	e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCell	Epithelial\|World / Lineage, Cell type, age group and donor	MAGI1 ABCA3 ACACA MET WWC1 PPP1R9A SHANK2 MAPK10 PDZD2	6.10e-07	192	225	9	499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCell	COPD-Epithelial\|COPD / Disease state, Lineage and Cell class	MAGI1 MET WWC1 PPP1R9A SHANK2 ENAH OSMR MAPK10 HYDIN	6.10e-07	192	225	9	0644fad5df18f0021f6f49cca996d8cf47f972ff
ToppCell	Epithelial-alveolar_epithelial_cell_type_2\|World / Lineage, Cell type, age group and donor	MAGI1 ABCA3 ACACA MET WWC1 PPP1R9A SHANK2 MAPK10 PDZD2	6.10e-07	192	225	9	58c3737be7acce39fd2b91d70d6d7b2bbaa4f710
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_myocytic\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	MAGI1 PAG1 SYNPO2 FRMPD4 SPEG NHS PCDH18 ANO4 COL12A1	6.37e-07	193	225	9	000b9e6a819b94ea2e6e9173daf97ba9ac2b6cc6
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 MYO9A WWC1 FRAS1 PKP4 PPP1R9A SHANK2 MAPK10 HYDIN	6.65e-07	194	225	9	93c68c31e39fa44c1d05d7d4997f4f086da4e738
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MAGI1 ABCA3 ACACA MET CARMIL1 PPP1R9A SHANK2 MAPK10 PDZD2	6.65e-07	194	225	9	97534c8bba895a7913665e03ae4e5c4a6ad71daf
ToppCell	RA-03._Atrial_Cardiomyocyte\|RA / Chamber and Cluster_Paper	MAGI1 CMYA5 SVIL PKP2 FRAS1 PPP1R9A SORBS1 ALPK2 PDZD2	6.65e-07	194	225	9	c3535f7cc0076653c72db582047cff053c322397
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_myocytic\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	MAGI1 PAG1 SYNPO2 FRMPD4 SPEG NHS PCDH18 ANO4 COL12A1	6.65e-07	194	225	9	67f5e2f05a8de2213ab80d5ea16fdee121684633
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 MYO9A NHS WWC1 FRAS1 PKP4 PPP1R9A SHANK2 MAPK10	6.94e-07	195	225	9	6477e6e7be5bd8eb99119a12ae16334ccddecd43
ToppCell	COPD-Multiplet\|COPD / Disease state, Lineage and Cell class	MAGI1 MET WWC1 SHANK2 ENAH MACF1 OSMR MAPK10 HYDIN	7.25e-07	196	225	9	6d02d494196e3f857d53eea46d9419690d43beca
ToppCell	COPD-Multiplet-Multiplet\|COPD / Disease state, Lineage and Cell class	MAGI1 MET WWC1 SHANK2 ENAH MACF1 OSMR MAPK10 HYDIN	7.25e-07	196	225	9	af4cdc61830685a888a1209826c23bcf54a43084
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 MYO9A NHS WWC1 FRAS1 PPP1R9A SHANK2 MAPK10 HYDIN	7.25e-07	196	225	9	6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	MAGI1 ACACA MYO9A ARID1B BRAF PPP1R9A SHANK2 MAPK10 PDZD2	7.89e-07	198	225	9	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MAGI1 ABCA3 ACACA MET WWC1 PPP1R9A SHANK2 MAPK10 PDZD2	8.23e-07	199	225	9	725610310e5c5fd7120c0be9acb55bf152026ddd
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	MAGI1 ACACA USP25 FOCAD ARID1B PTBP2 PPP1R9A RFX7 SHANK2	8.23e-07	199	225	9	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lect1_Oxtr\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SALL1 PTPRZ1 SVIL PCDH15 PCDH18 ANO4 KIF6 RGS12	9.39e-07	149	225	8	10ffd0051fb027bbebc662ca602c80d89bbf99c6
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo1_Itga4\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SALL1 PTPRZ1 SVIL PCDH18 ANO4 KIF6 RGS12 PKIB	1.26e-06	155	225	8	cba6f3f7742b4d5d54ad0a0ac0dd4016e73fe658
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FRMPD4 TMPRSS11D PCDH15 TDRD5 FRAS1 DNAH10 HYDIN UNC80	1.76e-06	162	225	8	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Htr2c\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SALL1 PTPRZ1 SVIL PCDH18 ANO4 FOSL2 RGS12 PKIB	2.02e-06	165	225	8	c6b23013d77fa9aa967b76e451c8e42b0a657c30
ToppCell	COVID-19-kidney-PEC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MET NHS WWC1 PRUNE2 FRAS1 SHANK2 HYDIN ALPK2	2.31e-06	168	225	8	a086c306be430adf0632ba53e98cd8014d2de330
ToppCell	Children_(3_yrs)-Epithelial-basal_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FRMPD4 MET PTPRZ1 NHS FRAS1 FERMT1 SHANK2 CLCA2	3.55e-06	178	225	8	fba2e38c05cbf031e0c6d47b1602575fea734a57
ToppCell	human_hepatoblastoma-Tumor_cells-T6\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	RUNDC3B NHS TACC1 PRUNE2 CARMIL1 FERMT1 ELK3 CRYBG3	3.70e-06	179	225	8	14fc8ccb6b215063d747643f47d780d2b237eb67
ToppCell	Control-Epithelial_cells-Airway_club\|Control / group, cell type (main and fine annotations)	MAGI1 MET SVIL PPP1R9A SHANK2 NCOA7 OSMR MAPK10	4.02e-06	181	225	8	c755d23dd9aabc717dc73e2b3fa99a1f751e6507
ToppCell	RA-07._Pericyte\|World / Chamber and Cluster_Paper	ARHGEF17 NHS TACC1 FN1 CARMIL1 COL5A3 MAPK10 PDZD2	4.18e-06	182	225	8	2075efeae633550fb2eb026d0dfd741c8252482e
ToppCell	COVID-19-kidney-PCT-S1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SALL1 NHS WWC1 PRUNE2 FRAS1 SHANK2 HYDIN ALPK2	4.36e-06	183	225	8	6878d14026c3df6aa12e45dfad94b32fa9d9b0b7
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive\|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	SYNPO2 SVIL NHS SORBS1 PHACTR3 MACF1 AKAP13 OSMR	4.54e-06	184	225	8	d2bf0135eb56bb410997dccea39c5ede88a0617f
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SALL1 PTPRZ1 CD163L1 PKP2 ANO4 POU3F4 RGS12 ROBO1	4.54e-06	184	225	8	32473dbdb2de66391157c5814ef34e790806e4f2
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	MAGI1 SYNPO2 CMYA5 SVIL PKP2 SORBS1 AKAP13 PDZD2	4.54e-06	184	225	8	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	COVID-19-Epithelial_cells-AT2\|COVID-19 / group, cell type (main and fine annotations)	ABCA3 ACACA MET WWC1 PPP1R9A SHANK2 MAPK10 PDZD2	4.54e-06	184	225	8	369b82f793deab672204558ae4e112cfa5aa9ccc
ToppCell	P03-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	PTPRZ1 COL28A1 COL5A3 POU3F4 PEX5L AATK PKIB PAX3	4.54e-06	184	225	8	8880ff36c243cc60a524d74934d000aef26a70ac
ToppCell	droplet-Heart-nan-3m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAGI1 LYST CEP350 SALL1 COL28A1 CBFA2T3 ATF7IP ELK3	4.91e-06	186	225	8	0ae5fbe9f210cb25092394267e1d3d6ed05627b8
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A MET MARCHF1 WWC1 PRUNE2 FRAS1 RGS12 LIX1	5.11e-06	187	225	8	c41a2c81dd2ceef303f39f699032aa7d6ea67cf0
ToppCell	COVID-19-Fibroblasts-Airway_smooth_muscle\|COVID-19 / group, cell type (main and fine annotations)	SYNPO2 SPEG NHS PRUNE2 COL12A1 FN1 SORBS1 ENAH	5.11e-06	187	225	8	464a0c3b92b778911b5f9cd73642e09e3472063a
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A GLI3 NHS WWC1 PRUNE2 PKP4 HYDIN PDZD2	5.11e-06	187	225	8	c31130fc2f9f882944b2ba366a034a03f051c4b9
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CMYA5 MET TMPRSS11D UAP1L1 PML FERMT1 MICALL1 PAX3	5.11e-06	187	225	8	a6a112689d1c9049f57935ad9d2f4955538427de
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SYNPO2 NHS ANO4 COL12A1 FN1 ENAH ROBO1 UNC80	5.11e-06	187	225	8	c104fbfef2d0bef64077ac721edf2379fd59d547
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SALL1 PTPRZ1 CD163L1 PKP2 NHS ANO4 RGS12 ROBO1	5.31e-06	188	225	8	6ee3f8f94ea7bdf652c9575fc65bff08070093a4
ToppCell	LA-13._Vascular_Smooth_Muscle\|LA / Chamber and Cluster_Paper	SYNPO2 SVIL NHS PRUNE2 FN1 SORBS1 ENAH MACF1	5.31e-06	188	225	8	34e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCell	COVID-19-Epithelial_cells\|COVID-19 / group, cell type (main and fine annotations)	MAGI1 ABCA3 MET WWC1 PPP1R9A SHANK2 MAPK10 PDZD2	5.31e-06	188	225	8	c9cdee6f8d42ee69f5fb335f25084603c511bd29
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A NHS WWC1 PRUNE2 PKP4 SHANK2 HYDIN PDZD2	5.31e-06	188	225	8	af740fa78542438fdff627ea1f74f4eee43316be
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A MET MARCHF1 WWC1 PRUNE2 SHANK2 HYDIN LIX1	5.31e-06	188	225	8	63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68
ToppCell	Control-Epithelial_cells\|Control / group, cell type (main and fine annotations)	MAGI1 ABCA3 MET WWC1 PPP1R9A SHANK2 MAPK10 PDZD2	5.31e-06	188	225	8	707ebf76cc6fb600b2f07793cf4ea9482c0de79d
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MET SVIL NHS FRAS1 BIRC3 PHACTR3 HYDIN LIX1	5.53e-06	189	225	8	aadb7a2de4cbe7f0958651f2739bba430b93f5c1
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CMYA5 GLI3 PCDH15 FRAS1 FN1 ECM2 PHACTR3 MAPK10	5.53e-06	189	225	8	203c80030df08ae112f9ae4043709f455d87ce89
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MET SVIL NHS FAM135A PKP4 PHACTR3 RXFP1 ALPK2	5.53e-06	189	225	8	8c8ca3b30d9be6c854615459a7bfba82b427c8bc
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MET SVIL NHS FRAS1 BIRC3 PHACTR3 HYDIN LIX1	5.53e-06	189	225	8	8977f3295b7df7c7474b3f371de90a82ae4bb50c
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MET SVIL NHS FAM135A PKP4 PHACTR3 RXFP1 ALPK2	5.53e-06	189	225	8	5d902a4660a27548764bf04c6de152b565da835c
ToppCell	TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma\|TCGA-Lung / Sample_Type by Project: Shred V9	COQ3 FAT2 PTPRZ1 USH1G TMPRSS11D MICALL1 DDIAS CLCA2	5.53e-06	189	225	8	aa4f7d7a5196e5ae481ebc2549de8e3f0ef6e6be
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A MET SALL1 WWC1 PRUNE2 FRAS1 RGS12 LIX1	5.74e-06	190	225	8	1cf023e3c6924d6a06f353d4b62444b6f2fee8a7
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A MET WWC1 COL28A1 PKP4 PHACTR3 HYDIN LIX1	5.74e-06	190	225	8	3fc9e18c7441c0ae8cda65753cc42d0520f4e116
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|RV / Chamber and Cluster_Paper	MAGI1 CMYA5 SVIL ABCG2 SORBS1 ENAH AKAP13 ALPK2	5.74e-06	190	225	8	93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A USP25 MET WWC1 PRUNE2 FRAS1 RGS12 LIX1	5.74e-06	190	225	8	59bbbd2c8d4b7ce46c54ca8022b1557e7e5eee2a
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SYNPO2 SPEG ARHGEF17 ACAN PCDH18 ANO4 PRUNE2 COL5A3	5.97e-06	191	225	8	7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4
ToppCell	Mesenchymal-vascular_smooth_muscle_cell\|World / Lineage, Cell type, age group and donor	SYNPO2 SPEG ARHGEF17 ACAN NHS COL12A1 SORBS1 ENAH	5.97e-06	191	225	8	fd89fbc62aa1c73e0f659991e3bd726a0c97bd68
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PAG1 SYNPO2 ARHGEF17 GLI3 COL12A1 FN1 COL5A3 RXFP1	5.97e-06	191	225	8	7b0d42a877540dbb346a76a62403e0d5d3e07fa6
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PAG1 SYNPO2 ARHGEF17 GLI3 COL12A1 FN1 COL5A3 RXFP1	5.97e-06	191	225	8	cd854b9c426924fdc84bf7f411f6dea447143e79
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|LV / Chamber and Cluster_Paper	MAGI1 SYNPO2 CMYA5 SVIL PKP2 SORBS1 AKAP13 PDZD2	5.97e-06	191	225	8	25f3eb34f4e70761e81e84c8a5829f216108cbc6
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	PAG1 FRMPD4 ARHGEF17 ACAN PCDH18 COL5A3 LIX1 PDZD2	6.20e-06	192	225	8	55f95454399fd533df75db06584eaa48d6ee3830
ToppCell	Control-Epithelial-Club\|Control / Disease state, Lineage and Cell class	MAGI1 MET NHS WWC1 PPP1R9A SHANK2 ENAH OSMR	6.20e-06	192	225	8	d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PAG1 SYNPO2 NREP PCDH18 ANO4 COL12A1 ROBO1 UNC80	6.20e-06	192	225	8	72881b280a415e65f87a80ca1369cbb0b722a0c4
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SALL1 PTPRZ1 CD163L1 PKP2 NHS ANO4 RGS12 ROBO1	6.20e-06	192	225	8	6a252e298f8a454623fa9c1c893a7a45a886d694
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	PAG1 FRMPD4 ARHGEF17 PCDH18 COL12A1 COL5A3 LIX1 PDZD2	6.20e-06	192	225	8	5000440dc1ed17e7474d340921bdff945646f27e
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SYNPO2 ARHGEF17 SVIL PCDH18 COL12A1 FN1 ECM2 COL5A3	6.44e-06	193	225	8	2ddf9b2770a0be9689e01d1a3d19e4a6d42c7a50
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	ARID1B TACC1 MAP4K4 FRAS1 PTBP2 PPP1R9A ZFC3H1 ROBO1	6.44e-06	193	225	8	e6a688bc834f845ff64dae1be64f073eec5091a1
Drug	Pempidine tartrate [546-48-5]; Down 200; 13uM; PC3; HT_HG-U133A	LYST DHX9 CEP350 MET UBN1 EEA1 SLC23A2 PKP4 PPP1R9A NUMA1 MED1 AKAP13	3.69e-07	190	221	12	4307_DN
Drug	Azaguanine-8 [134-58-7]; Down 200; 26.2uM; MCF7; HT_HG-U133A	DCAF8 KIAA0586 SETDB1 KMT2A TACC1 SLC23A2 ZFC3H1 DENND4C PIAS4 TRAPPC10 MACF1 GGA1	4.62e-07	194	221	12	1670_DN
Drug	Zalcitabine [7481-89-2]; Down 200; 19uM; MCF7; HT_HG-U133A	MAGI1 NAB2 MET NBEAL2 SVIL PML DRD1 AHCYL2 WRAP53 MICALL1 PIAS4 OSMR	5.44e-07	197	221	12	7352_DN
Drug	Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; PC3; HT_HG-U133A	NREP DHX9 MET EEA1 PML FAM234B FN1 PKP4 NUMA1 VPS13D AKAP13 SENP7	5.74e-07	198	221	12	4282_DN
Drug	haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A	DCAF8 ITPRID2 TECPR2 KMT2A HSF2 FN1 PKP4 DENND4C VPS13D THADA ROBO1 ZFYVE26	6.06e-07	199	221	12	6963_DN
Drug	Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A	MAGI1 DCAF8 RUNDC3B KIAA0586 OSGEPL1 GLI3 TACC1 WDR62 WRAP53 E2F8 MACF1	2.41e-06	188	221	11	6451_DN
Drug	LY 294002; Down 200; 10uM; HL60; HT_HG-U133A	SP2 NBEAL2 SVIL EEA1 MAP4K4 PML FN1 TCOF1 FERMT1 TWNK AHCYL2	2.54e-06	189	221	11	1168_DN
Drug	Acebutolol hydrochloride [34381-68-5]; Up 200; 10.8uM; PC3; HG-U133A	MYO9A SPEG NAB2 TSC2 SETDB1 ACAN ANAPC2 FAM118A HSPG2 FOSL2 AKAP13	3.44e-06	195	221	11	1911_UP
Drug	Demecarium bromide [56-94-0]; Down 200; 5.6uM; HL60; HG-U133A	ACACA KIAA0586 SETDB1 TECPR2 ACAN GORASP1 PML FN1 MICALL1 PIAS4 VPS13D	3.61e-06	196	221	11	1781_DN
Drug	Nafcillin sodium salt monohydrate [7177-50-6]; Down 200; 8.8uM; PC3; HT_HG-U133A	NAB2 DHX9 MET NBEAL2 PML FAM234B ATN1 FOSL2 PPP1R9A AKAP13 ELK3	3.79e-06	197	221	11	3983_DN
Drug	Ganciclovir [82410-32-0]; Down 200; 15.6uM; PC3; HT_HG-U133A	ABCA3 MET SETDB1 BRAF SLC23A2 PML FAM234B PKP4 THADA SHANK2 AKAP13	3.79e-06	197	221	11	6289_DN
Drug	Proglumide [6620-60-6]; Down 200; 12uM; PC3; HT_HG-U133A	NAB1 MET SYNJ1 FAM118A MRTFA PML HSPG2 ATN1 ELK3 OSMR SENP7	3.79e-06	197	221	11	4337_DN
Drug	Napelline [5008-52-6]; Down 200; 11.2uM; PC3; HT_HG-U133A	NREP LYST DHX9 HOXA2 SETDB1 UAP1L1 MRTFA PML AATK ELK3 GGA1	3.98e-06	198	221	11	4486_DN
Drug	Tridihexethyl chloride; Down 200; 11.4uM; PC3; HT_HG-U133A	ABCA3 NAB2 UBN1 TECPR2 SLC23A2 PML FAM234B NCKIPSD NUMA1 ZNF335 GGA1	3.98e-06	198	221	11	5067_DN
Drug	Lanatoside C [17575-22-3]; Up 200; 4uM; MCF7; HT_HG-U133A	NAB2 CEP350 PKP2 KMT2A HSF2 SLC23A2 CDKN2AIP FOSL2 ATF7IP ZNF335	4.83e-06	164	221	10	3852_UP
Drug	Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A	DHX9 CEP350 MET UBN1 KMT2A EEA1 PKP4 AGGF1 MED1 AKAP13	9.97e-06	178	221	10	3998_DN
Drug	Dicumarol [66-76-2]; Down 200; 11.8uM; PC3; HT_HG-U133A	CHM LYST DHX9 MET UBN1 KMT2A SLC23A2 NUMA1 RFX7 OSMR	1.53e-05	187	221	10	4323_DN
Drug	Pempidine tartrate [546-48-5]; Down 200; 13uM; MCF7; HT_HG-U133A	DHX9 UBN1 KMT2A EEA1 ATN1 PPP1R9A NUMA1 AGGF1 RGS12 AKAP13	1.84e-05	191	221	10	3926_DN
Drug	Pronethalol hydrochloride [51-02-5]; Down 200; 15uM; MCF7; HT_HG-U133A	DHX9 UBN1 KMT2A FKBP15 PKP4 NUMA1 AGGF1 RFX7 MICALL1 AKAP13	1.93e-05	192	221	10	4104_DN
Drug	lapatinib	DHX9 MET ABCG2 HSPG2 NCKIPSD TWNK MAPK10	2.07e-05	86	221	7	CID000208908
Drug	Pimethixene maleate [13187-06-9]; Down 200; 9.8uM; MCF7; HT_HG-U133A	DCAF8 TACC1 SLC23A2 WWC1 CARMIL1 FERMT1 AHCYL2 MED1 SHANK2 MACF1	2.11e-05	194	221	10	7468_DN
Drug	Tranexamic acid [1197-18-8]; Down 200; 25.4uM; PC3; HT_HG-U133A	CHM LYST HOXA2 PML FN1 NUMA1 DALRD3 PIAS4 VPS13D OSMR	2.11e-05	194	221	10	5762_DN
Drug	Clopamide [636-54-4]; Up 200; 11.6uM; PC3; HT_HG-U133A	DCAF8 NAB2 TECPR2 MINAR1 FAM118A FKBP15 FOSL2 PKP4 RGS12 VPS13D	2.20e-05	195	221	10	6301_UP
Drug	PF-00539745-00 [351321-33-0]; Down 200; 10uM; PC3; HT_HG-U133A	SETDB1 ABCG2 PML ATN1 FN1 RGS12 AKAP13 ELK3 OSMR SENP7	2.20e-05	195	221	10	5979_DN
Drug	Cefepime hydrochloride [123171-59-5]; Down 200; 7.4uM; HL60; HT_HG-U133A	NAB1 CHM LYST CEP350 KMT2A EEA1 PML PKP4 NUMA1 AGGF1	2.20e-05	195	221	10	6159_DN
Drug	Riluzole hydrochloride; Down 200; 14.8uM; MCF7; HT_HG-U133A	ARHGEF17 LYST CEP350 HSF2 PML DRD1 ATN1 TCOF1 NCKIPSD AHCYL2	2.30e-05	196	221	10	4689_DN
Drug	Acyclovir [59277-89-3]; Up 200; 17.8uM; PC3; HT_HG-U133A	NOL4 ZNF236 CHM KMT2A MRTFA WDR62 PML FN1 PEX5L RGS12	2.30e-05	196	221	10	4683_UP
Drug	troglitazone; Down 200; 10uM; MCF7; HT_HG-U133A_EA	SP2 ABCA3 ZNF236 NEO1 FKBP15 NCKIPSD E2F8 VPS13D SHANK2 ROBO1	2.51e-05	198	221	10	1070_DN
Drug	Rilmenidine hemifumarate [54187-04-1]; Up 200; 8.4uM; PC3; HT_HG-U133A	MAGI1 ARHGEF17 SETDB1 PML HSPG2 PKP4 SORBS1 RGS12 MICALL1 TRAPPC10	2.51e-05	198	221	10	5107_UP
Drug	Betulinic acid [472-15-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A	CEP350 SETDB1 SVIL WDR62 PPP1R9A FERMT1 AHCYL2 RGS12 VPS13D OSMR	2.51e-05	198	221	10	3281_DN
Drug	Guanethidine sulfate [60-02-6]; Up 200; 13.4uM; HL60; HG-U133A	SNX19 NEFH TECPR2 SLC23A2 NUMA1 ARHGEF18 AHCYL2 THADA AATK AKAP13	2.62e-05	199	221	10	1554_UP
Drug	SC-58125; Up 200; 10uM; MCF7; HG-U133A	SPEG NAB2 ACAN PCYT1B ATN1 ECM2 FERMT1 POU3F4 RGS12 MICALL1	2.62e-05	199	221	10	254_UP
Drug	Amprolium hydrochloride [137-88-2]; Up 200; 12.6uM; HL60; HG-U133A	ACACA SNX19 KMT2A SLC23A2 FN1 AHCYL2 MED1 MICALL1 TRAPPC10 GGA1	2.62e-05	199	221	10	1979_UP
Drug	Etidronic acid, disodium salt [7414-83-7]; Down 200; 16uM; PC3; HT_HG-U133A	NAB2 CHM NREP MET SETDB1 TECPR2 NUMA1 VPS13D AKAP13 OSMR	2.62e-05	199	221	10	4564_DN
Drug	Benoxinate hydrochloride [5987-82-6]; Up 200; 11.6uM; MCF7; HT_HG-U133A	RUNDC3B SPEG ARHGEF17 SYNJ1 CACNA1G WDR62 PML ATN1 PPP1R9A MICALL1	2.62e-05	199	221	10	4115_UP
Drug	Tetracaone hydrochloride [136-47-0]; Down 200; 13.2uM; MCF7; HT_HG-U133A	UFSP2 NAB2 KIAA0586 MET NBEAL2 EEA1 HSF2 PML MED1 ZNF335	2.62e-05	199	221	10	7473_DN
Drug	Artemisinin [63968-64-9]; Up 200; 14.2uM; HL60; HG-U133A	ACACA NEFH ACAN NBEAL2 SLC23A2 FN1 NCKIPSD PIAS4 ZNF335 GGA1	2.74e-05	200	221	10	1714_UP
Drug	Proscillaridin A [466-06-8]; Up 200; 7.6uM; MCF7; HT_HG-U133A	KMT2A EEA1 HSF2 PTBP2 CDKN2AIP FOSL2 MED1 ATF7IP ZNF335	2.76e-05	160	221	9	4404_UP
Drug	Digitoxigenin [143-62-4]; Up 200; 10.6uM; HL60; HT_HG-U133A	NAB2 PML CDKN2AIP NUMA1 BIRC3 MED1 ATF7IP ZNF335 ZBTB11	3.04e-05	162	221	9	1339_UP
Drug	Helveticoside [630-64-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A	NAB2 CEP350 KMT2A HSF2 DRD1 CDKN2AIP FOSL2 ATF7IP ZNF335	3.51e-05	165	221	9	3851_UP
Drug	Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; HL60; HT_HG-U133A	CEP350 CDKN2AIP NUMA1 BIRC3 MED1 ATF7IP ZNF335 AKAP13 ZBTB11	5.32e-05	174	221	9	1302_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A	NOL4 RUNDC3B LYST FAM118A UAP1L1 TFEC BIRC3 SORBS1 AKAP13	5.32e-05	174	221	9	6609_UP
Drug	zinc nitrate	CHM CHMP2A POU3F4	7.26e-05	9	221	3	CID000024518
Drug	AC1L1B35	SP2 NAB2 GABRQ LYST NEFH WWC1	8.35e-05	74	221	6	CID000001263
Drug	demethyl	COQ3 PKDREJ ACAN ENAH	9.31e-05	25	221	4	CID000005877
Drug	roxarsone	GLI3 MARCHF1 NCKIPSD SHANK2	9.31e-05	25	221	4	CID000005104
Drug	JM118	ACD ABCG2	9.38e-05	2	221	2	CID000130456
Drug	Adenosine 5'-monophosphate monohydrate [18422-05-4]; Down 200; 11uM; HL60; HG-U133A	DCAF8 ACACA DHX9 NEFH FN1 TCOF1 TWNK VPS13D GGA1	9.65e-05	188	221	9	1622_DN
Drug	Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A	CHM DHX9 CEP350 MET KMT2A EEA1 SLC23A2 PKP4 AGGF1	9.65e-05	188	221	9	6735_DN
Drug	Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A	DHX9 CEP350 KMT2A TACC1 TSTD2 TCOF1 PKP4 AHCYL2 WRAP53	9.65e-05	188	221	9	4845_DN
Drug	emtricitabine	DHX9 MET BRAF ABCG2 MED1 B4GALNT2 AKAP13 RXFP1	9.74e-05	147	221	8	CID000060877
Drug	Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; PC3; HT_HG-U133A	NREP DHX9 CEP350 MET KMT2A SLC23A2 PKP4 NUMA1 E2F8	1.00e-04	189	221	9	4271_DN
Drug	Ketanserin tartrate hydrate [83846-83-7]; Down 200; 7uM; PC3; HT_HG-U133A	NAB2 DHX9 CEP350 MET KMT2A NUMA1 AGGF1 MED1 AKAP13	1.00e-04	189	221	9	6649_DN
Drug	Tolbutamide [64-77-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A	NAB2 CEP350 KMT2A SLC23A2 PML HSPG2 PPP1R9A AGGF1 MED1	1.05e-04	190	221	9	4362_DN
Drug	Fenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A	CHM CEP350 MET FAM234B PPP1R9A NUMA1 AGGF1 MED1 AKAP13	1.09e-04	191	221	9	4279_DN
Drug	11-deoxy-16,16-dimethyl Prostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A	SLC23A2 WWC1 PML FAM234B ATN1 AHCYL2 MED1 DALRD3 AKAP13	1.09e-04	191	221	9	7538_UP
Drug	Proglumide [6620-60-6]; Up 200; 12uM; MCF7; HT_HG-U133A	SPEG ARHGEF17 DHX9 KMT2A CACNA1G PRUNE2 FKBP15 ATN1 OSMR	1.09e-04	191	221	9	3861_UP
Drug	Zaprinast [37762-06-4]; Down 200; 14.8uM; PC3; HT_HG-U133A	SPEG NAB2 CHM MRTFA PML FKBP15 NUMA1 VPS13D OSMR	1.18e-04	193	221	9	6749_DN
Drug	Solasodine [126-17-0]; Down 200; 9.6uM; PC3; HT_HG-U133A	CHM LYST DHX9 MET EEA1 SLC23A2 NUMA1 AGGF1 AKAP13	1.18e-04	193	221	9	4305_DN
Drug	geldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A	KIAA0586 TECPR2 OSGEPL1 TACC1 UAP1L1 WWC1 TCOF1 CBFA2T3 GGA1	1.18e-04	193	221	9	1653_DN
Drug	Ethynodiol diacetate [297-76-7]; Down 200; 10.4uM; MCF7; HT_HG-U133A	DCAF8 MYO9A LYST SETDB1 CDKN2AIP NUMA1 AGGF1 ZNF335 ROBO1	1.18e-04	193	221	9	5024_DN
Drug	Ursolic acid [77-52-1]; Up 200; 8.8uM; PC3; HT_HG-U133A	NAB2 DHX9 SQSTM1 UAP1L1 AHCYL2 RFX7 VPS13D AKAP13 ELK3	1.18e-04	193	221	9	2067_UP
Drug	Bucladesine sodium salt [16980-89-5]; Down 200; 7.8uM; HL60; HT_HG-U133A	NAB1 CHM SYNJ1 EEA1 UAP1L1 WDR62 HSPG2 PKP4 WRAP53	1.23e-04	194	221	9	2741_DN
Drug	0317956-0000 [391210-11-0]; Up 200; 10uM; MCF7; HT_HG-U133A	RUNDC3B KMT2A ATN1 FOSL2 NUMA1 RGS12 VPS13D AKAP13 SENP7	1.23e-04	194	221	9	3855_UP
Drug	lomustine; Down 200; 100uM; MCF7; HT_HG-U133A	MAGI1 DHX9 GLI3 TACC1 WDR62 FAM234B FERMT1 WRAP53 MACF1	1.23e-04	194	221	9	7089_DN
Drug	H-89, Dihydrochloride; Up 200; 0.5uM; PC3; HT_HG-U133A	DHX9 SETDB1 ANAPC2 KMT2A EEA1 SLC23A2 HSPG2 MED1 AKAP13	1.23e-04	194	221	9	6921_UP
Drug	Ethoxyquin [91-53-2]; Up 200; 18.4uM; MCF7; HT_HG-U133A	SPEG LYST MET FRAS1 ATN1 FOSL2 RGS12 CTF1 MAPK10	1.23e-04	194	221	9	3846_UP
Drug	Orphenadrine hydrochloride [341-69-5]; Up 200; 13uM; PC3; HT_HG-U133A	MRTFA WDR62 PML FAM234B BIRC3 POM121L2 CLCA2 MAPK10 SENP7	1.23e-04	194	221	9	4537_UP
Drug	Harmaline hydrochloride dihydrate [6027-98-1]; Up 200; 14uM; MCF7; HT_HG-U133A	ABCA3 TECPR2 UAP1L1 HSPG2 ATN1 FN1 POM121L2 RGS12 CLCA2	1.27e-04	195	221	9	2805_UP
Drug	Clomiphene citrate (Z,E) [50-41-9]; Down 200; 6.6uM; MCF7; HT_HG-U133A	MAGI1 NAB2 ITPRID2 MET SETDB1 FAM118A SLC23A2 NUMA1 AGGF1	1.27e-04	195	221	9	4994_DN
Drug	Prenylamine lactate [69-43-2]; Down 200; 9.6uM; PC3; HT_HG-U133A	ABCA3 NAB2 GLI3 SLC23A2 PML WRAP53 E2F8 SHANK2 GGA1	1.27e-04	195	221	9	5070_DN
Drug	2-propylpentanoic acid; Down 200; 200uM; MCF7; HT_HG-U133A	DCAF8 MYO9A ECSIT MET SLC23A2 MRTFA HSPG2 NCKIPSD GGA1	1.27e-04	195	221	9	1639_DN
Drug	5707885; Up 200; 50uM; PC3; HT_HG-U133A	MAGI1 SQSTM1 MINAR1 ABCG2 HSF2 ATN1 FN1 PIAS4 CTF1	1.27e-04	195	221	9	6390_UP
Drug	Mexiletine hydrochloride [5370-01-4]; Up 200; 18.6uM; MCF7; HT_HG-U133A	NAB2 LYST ACAN PKP2 KMT2A FN1 FOSL2 AGGF1 VPS13D	1.27e-04	195	221	9	3862_UP
Drug	Panthenol (D) [81-13-0]; Down 200; 19.4uM; MCF7; HT_HG-U133A	DCAF8 NAB2 KIAA0586 LYST UBN1 TACC1 FOSL2 FERMT1 ROBO1	1.32e-04	196	221	9	7455_DN
Drug	Tetramisole hydrochloride [16595-80-5]; Down 200; 16.6uM; PC3; HT_HG-U133A	SPEG NAB2 NREP PML PKP4 NCKIPSD VPS13D AKAP13 OSMR	1.32e-04	196	221	9	4587_DN
Drug	SC-58125; Down 200; 10uM; SKMEL5; HG-U133A	NAB2 SQSTM1 GORASP1 PML ATN1 FERMT1 MICALL1 VPS13D PCNT	1.32e-04	196	221	9	507_DN
Drug	Iopamidol [60166-93-0]; Up 200; 5.2uM; MCF7; HT_HG-U133A	DCAF8 NAB2 SETDB1 SYNJ1 FAM118A PML DENND4C TRAPPC10 OSMR	1.32e-04	196	221	9	3473_UP
Drug	Ramipril [87333-19-5]; Up 200; 9.6uM; MCF7; HT_HG-U133A	ZNF236 CHM ATN1 FOSL2 PPP1R9A AHCYL2 WRAP53 ELK3 SENP7	1.32e-04	196	221	9	3572_UP
Drug	Oxprenolol hydrochloride [6452-73-9]; Down 200; 13.2uM; HL60; HT_HG-U133A	CHM SYNJ1 SQSTM1 SLC23A2 PML PKP4 NUMA1 AKAP13 ZFYVE26	1.38e-04	197	221	9	6145_DN
Drug	Cefazolin sodium salt [27164-46-1]; Up 200; 8.4uM; PC3; HT_HG-U133A	MAGI1 NAB2 SALL1 PML PRUNE2 FN1 POM121L2 POU3F4 AATK	1.38e-04	197	221	9	3686_UP
Drug	Pyrithyldione [77-04-3]; Up 200; 24uM; MCF7; HT_HG-U133A	LYST MET WDR62 FN1 PPP1R9A BIRC3 VPS13D AATK ELK3	1.38e-04	197	221	9	6801_UP
Drug	SC-58125; Up 200; 10uM; HL60; HG-U133A	NEO1 OSGEPL1 GLI3 MAP4K4 SLC23A2 TCOF1 MED1 THADA GGA1	1.38e-04	197	221	9	542_UP
Drug	0225151-0000 [351320-15-5]; Up 200; 10uM; PC3; HT_HG-U133A	SYNJ1 HSF2 SLC23A2 PML PKP4 SORBS1 CBFA2T3 RGS12 PIAS4	1.38e-04	197	221	9	6389_UP
Drug	(-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Down 200; 12.2uM; PC3; HT_HG-U133A	ZNF236 DHX9 SLC23A2 PML FKBP15 BIRC3 MED1 AKAP13 SENP7	1.38e-04	197	221	9	5108_DN
Drug	Dicloxacillin sodium salt [13412-64-1]; Up 200; 8.2uM; MCF7; HT_HG-U133A	SPEG ZNF236 SQSTM1 MINAR1 MRTFA PRUNE2 NUMA1 SORBS1 RGS12	1.38e-04	197	221	9	3307_UP
Drug	LY294002; Down 200; 10uM; SKMEL5; HG-U133A	ACACA MYO9A GABRQ UBN1 ACAN PCYT1B PKP4 PPP1R9A SORBS1	1.43e-04	198	221	9	501_DN
Drug	Bromopride [4093-35-0]; Up 200; 11.6uM; MCF7; HT_HG-U133A	ARHGEF17 LYST WDR62 PML PRUNE2 ATN1 BIRC3 RGS12 GGA1	1.43e-04	198	221	9	6037_UP
Drug	fluphenazine dihydrochloride; Down 200; 10uM; PC3; HT_HG-U133A	SPEG KIAA0586 HOXA2 HSF2 WWC1 FAM234B NCKIPSD E2F8 POLQ	1.43e-04	198	221	9	1237_DN
Drug	Deltaline [6836-11-9]; Up 200; 7.8uM; MCF7; HT_HG-U133A	ACAN PKP2 KMT2A CACNA1G SLC23A2 ATN1 FN1 RGS12 PAX3	1.43e-04	198	221	9	6026_UP
Drug	Novobiocin sodium salt [1476-53-5]; Down 200; 6.4uM; PC3; HT_HG-U133A	SPEG CHM NBEAL2 SVIL FAM118A PML FAM234B ATN1 OSMR	1.43e-04	198	221	9	4569_DN
Drug	Lidocaone hydrochloride [73-78-9]; Up 200; 14.8uM; PC3; HG-U133A	MYO9A SETDB1 ACAN HSPG2 MED1 WRAP53 VPS13D AKAP13 PDZD2	1.43e-04	198	221	9	1917_UP
Drug	Dantrolene sodium salt [14663-23-1]; Up 200; 11.8uM; PC3; HT_HG-U133A	ZNF236 LYST DHX9 MET ACAN MINAR1 FAM135A NUMA1 POU3F4	1.43e-04	198	221	9	4343_UP
Drug	Fenbendazole [43210-67-9]; Down 200; 13.4uM; PC3; HT_HG-U133A	NAB2 NREP UBN1 GLI3 HSPG2 FKBP15 NUMA1 PIAS4 ELK3	1.43e-04	198	221	9	3805_DN
Drug	minocycline; Down 200; 10.5uM; MCF7; HT_HG-U133A_EA	SP2 TSC2 KMT2A FN1 TCOF1 CARMIL1 RFX7 ZNF335 POLQ	1.43e-04	198	221	9	1135_DN
Drug	U-62066 [87151-85-7]; Down 200; 1uM; MCF7; HT_HG-U133A	MRTFA WDR62 PML HSPG2 DRD1 ATN1 FOSL2 DALRD3 MICALL1	1.43e-04	198	221	9	3901_DN
Drug	ionomycin calcium salt; Down 200; 2uM; MCF7; HT_HG-U133A_EA	SP2 NAB2 OSGEPL1 TACC1 MRTFA AHCYL2 WRAP53 DALRD3 TRAPPC10	1.43e-04	198	221	9	871_DN
Drug	Verapamyl hydrochloride [152-11-4]; Up 200; 8.2uM; MCF7; HT_HG-U133A	NBEAL2 KMT2A MRTFA ATN1 FOSL2 SORBS1 AATK SENP7 PDZD2	1.43e-04	198	221	9	5387_UP
Drug	Ajmaline [4360-12-7]; Down 200; 12.2uM; MCF7; HT_HG-U133A	DCAF8 SQSTM1 NBEAL2 KMT2A FKBP15 FOSL2 FERMT1 AGGF1 RGS12	1.43e-04	198	221	9	7484_DN
Drug	Ethosuximide [77-67-8]; Up 200; 28.4uM; HL60; HG-U133A	NAB2 TSC2 SNX19 MET GLI3 NBEAL2 PML FN1 AATK	1.48e-04	199	221	9	1433_UP
Disease	diastolic blood pressure, systolic blood pressure	MYO9A SPEG SNX19 CEP350 MET ARID1B ACAN SVIL CCDC201 WDR62 CARMIL1 ARHGAP9 COL5A3 CBFA2T3 RGS12 KIAA1671 CLCA2	1.28e-05	670	220	17	EFO_0006335, EFO_0006336
Disease	autism spectrum disorder (implicated_via_orthology)	ABCA3 TSC2 MET ARID1B PKP2 PKP4 SHANK2 ELP2	1.96e-05	152	220	8	DOID:0060041 (implicated_via_orthology)
Disease	nucleus accumbens volume change measurement	WWC1 MUC16 MAPK10	6.45e-05	11	220	3	EFO_0021493
Disease	cortical surface area measurement	MAGI1 DCHS2 FSIP1 ATP6AP1L PLEKHM1 FOCAD NEO1 ARID1B GLI3 TACC1 FAM118A MAP4K4 GPANK1 ARHGAP21 WWC1 ANO4 KIF6 FAM117B THADA MACF1 ROBO1 ELK3 PAX3 PDZD2	7.33e-05	1345	220	24	EFO_0010736
Disease	cognitive function measurement	MAGI1 SYNPO2 FRMPD4 NREP LIN52 ATP6AP1L PLEKHM1 ARID1B CD163L1 GLI3 TMPRSS11D TACC1 EEA1 MARCHF1 ARHGAP21 MRTFA TSNARE1 NCKIPSD POM121L2 ARHGAP9 ATF7IP ZNF335 PHACTR3 PRDM14 HYDIN	7.46e-05	1434	220	25	EFO_0008354
Disease	cortical thickness	MAGI1 ATP6AP1L PLEKHM1 NEO1 ARID1B UBN1 GLI3 KMT2A TACC1 ARHGAP21 HSPG2 KIF6 COL12A1 PTBP2 MICALL1 VPS13D THADA MACF1 ROBO1 OSMR PDZD2	9.82e-05	1113	220	21	EFO_0004840
Disease	Hypopigmentation disorder	GLI3 EPG5	1.65e-04	3	220	2	C0162835
Disease	interleukin-18-binding protein measurement	XNDC1N NUMA1	1.65e-04	3	220	2	EFO_0020495
Disease	Malignant mesothelioma	MET SETDB1 WWC1 COL12A1 FN1 OSMR	1.72e-04	109	220	6	C0345967
Disease	Malignant neoplasm of breast	ABCA3 KCNIP3 PKDREJ ATP6AP1L ARID1B BRAF NHS ABCG2 KIF6 FN1 SORBS1 ECT2 EPG5 MICALL1 CLCA2 MACF1 ROBO1 ZFYVE26 ELK3 GGA1	1.72e-04	1074	220	20	C0006142
Disease	Congenital small ears	HOXA2 SALL1 FRAS1 TCOF1	2.45e-04	41	220	4	C0152423
Disease	heart rate variability measurement, response to antipsychotic drug	COL12A1 ARHGAP9 E2F8 OSMR	3.84e-04	46	220	4	EFO_0008003, GO_0097332
Disease	cup-to-disc ratio measurement	SERPINE3 SALL1 GLI3 KMT2A KIF6 FRAS1 COL12A1 FERMT1 NCKIPSD ARHGAP9 PDZD2	4.15e-04	430	220	11	EFO_0006939
Disease	Giant Cell Glioblastoma	MET TACC1 PML FN1 FOSL2	4.21e-04	84	220	5	C0334588
Disease	Usher syndrome, type 1A	USH1G PCDH15	5.45e-04	5	220	2	C2931205
Disease	USHER SYNDROME, TYPE IB (disorder)	USH1G PCDH15	5.45e-04	5	220	2	C1848638
Disease	USHER SYNDROME, TYPE IA, FORMERLY	USH1G PCDH15	5.45e-04	5	220	2	C1848639
Disease	USHER SYNDROME, TYPE I, FRENCH VARIETY, FORMERLY	USH1G PCDH15	5.45e-04	5	220	2	C1848640
Disease	Usher syndrome type 1	USH1G PCDH15	5.45e-04	5	220	2	cv:C1568247
Disease	Usher Syndrome, Type I	USH1G PCDH15	8.14e-04	6	220	2	C1568247
Disease	Hereditary retinal dystrophy	USH1G PCDH15	1.13e-03	7	220	2	C0154860
Disease	Usher syndrome	USH1G PCDH15	1.13e-03	7	220	2	cv:C0271097
Disease	acute promyelocytic leukemia (is_implicated_in)	PML NUMA1	1.13e-03	7	220	2	DOID:0060318 (is_implicated_in)
Disease	hair morphology	SLC23A2 FRAS1 THADA	1.29e-03	29	220	3	EFO_0005038
Disease	serum gamma-glutamyl transferase measurement	MYO9A FSIP1 MET SALL1 NBEAL2 SVIL KMT2A ARHGAP21 FOSL2 TWNK THADA ENAH ZFP91 ROBO1 AKAP13 ALPK2	1.46e-03	914	220	16	EFO_0004532
Disease	7-methylguanine measurement	PPP1R9A ELP2	1.50e-03	8	220	2	EFO_0021123
Disease	Liver carcinoma	ACACA RNF157 MET ARID1B BRAF KMT2A WDR62 MED1 ECT2 E2F8 ROBO1	1.58e-03	507	220	11	C2239176
Disease	Polydactyly	KIAA0586 SALL1 GLI3 TBX22 FRAS1	1.88e-03	117	220	5	C0152427
Disease	dentures	NEO1 SALL1 FAM118A PRUNE2	1.88e-03	70	220	4	EFO_0010078
Disease	dental caries, dentures	NEO1 SALL1 FAM118A PRUNE2	1.88e-03	70	220	4	EFO_0003819, EFO_0010078
Disease	Osteitis Deformans	SQSTM1 PML	1.92e-03	9	220	2	C0029401
Disease	cup-to-disc ratio measurement, optic cup area measurement, optic disc area measurement	SERPINE3 KIF6	2.39e-03	10	220	2	EFO_0006937, EFO_0006939, EFO_0006940
Disease	age at menarche, spine bone mineral density	RUNDC3B PCDH15	2.39e-03	10	220	2	EFO_0004703, EFO_0007701
Disease	unipolar depression, anorexia nervosa	PTBP2 NCKIPSD	2.39e-03	10	220	2	EFO_0003761, MONDO_0005351
Disease	Acute Myeloid Leukemia, M1	TSC2 MET SVIL KMT2A ENAH	2.50e-03	125	220	5	C0026998
Disease	Acute Myeloid Leukemia (AML-M2)	TSC2 MET SVIL KMT2A ENAH	2.50e-03	125	220	5	C1879321
Disease	Disproportionate short stature	ACAN GLI3 HSPG2 PCNT	2.66e-03	77	220	4	C0878659
Disease	sexual dysfunction	ARHGEF18 EPC1	2.91e-03	11	220	2	EFO_0004714
Disease	interleukin-6 measurement, response to stimulus	CARMIL1 MUC16	2.91e-03	11	220	2	EFO_0004810, GO_0050896
Disease	Cleft palate, tobacco smoke exposure measurement, cleft lip, parental genotype effect measurement	FOCAD MAPK10	2.91e-03	11	220	2	EFO_0003959, EFO_0005939, EFO_0009115, HP_0000175
Disease	Glioblastoma	MET PML FN1 FOSL2	2.92e-03	79	220	4	C0017636
Disease	Nonsyndromic Deafness	MET USH1G PCDH15 POU3F4	3.20e-03	81	220	4	C3711374
Disease	nose morphology measurement	DCHS2 GLI3 TBX22 KIF6 SORBS1 THADA ROBO1 PAX3	3.42e-03	329	220	8	EFO_0007843
Disease	acute myeloid leukemia (implicated_via_orthology)	KMT2A ZFP91	3.48e-03	12	220	2	DOID:9119 (implicated_via_orthology)
Disease	alcohol use disorder (implicated_via_orthology)	PSD ARID1B KCNU1 UNC79 DRD1 PSD2	3.53e-03	195	220	6	DOID:1574 (implicated_via_orthology)
Disease	autistic disorder (is_implicated_in)	MET SETDB1 SHANK2	3.79e-03	42	220	3	DOID:12849 (is_implicated_in)
Disease	hip circumference	PLEKHM1 BRAF TXNDC2 DNAH10 POM121L2 MICALL1 SHANK2 ALPK2	4.03e-03	338	220	8	EFO_0005093
Disease	pyruvate measurement	ACAN PCDH15 FAM118A MARCHF1 COL28A1 RGS12 HYDIN	4.13e-03	268	220	7	EFO_0010117
Disease	optic disc area measurement	SERPINE3 ARHGAP21 KIF6	4.61e-03	45	220	3	EFO_0006937
Disease	Malignant neoplasm of kidney	TSC2 MET BRAF	4.61e-03	45	220	3	C0740457
Disease	Pneumoconiosis	PTPRZ1 ACAN	4.75e-03	14	220	2	C0032273
Disease	Bagassosis	PTPRZ1 ACAN	4.75e-03	14	220	2	C0004681
Disease	Hereditary hearing loss and deafness	USH1G PCDH15 TWNK POU3F4 PAX3	4.86e-03	146	220	5	cv:C0236038
Disease	FEV/FEC ratio	DCHS2 ABCA3 DCAF8 SPEG KIAA0586 ARHGEF17 MET ACAN SVIL MRTFA PML HSPG2 FRAS1 ARHGEF18 THADA EPC1 MAPK10 LRRC37B	5.07e-03	1228	220	18	EFO_0004713
Disease	susceptibility to chickenpox measurement	NOL4 NREP MARCHF1	5.21e-03	47	220	3	EFO_0008400
Disease	cognitive function measurement, self reported educational attainment	NREP ATP6AP1L PLEKHM1 ARID1B EEA1 MRTFA CARMIL1 TSNARE1	5.38e-03	355	220	8	EFO_0004784, EFO_0008354
Disease	Autosomal recessive primary microcephaly	WDR62 ZNF335	5.45e-03	15	220	2	cv:C3711387
Disease	response to fenofibrate	GLI3 AHCYL2 SHANK2	6.19e-03	50	220	3	GO_1901557
Disease	Gastrointestinal Stromal Tumors	BRAF GLI3 ZBTB11	6.19e-03	50	220	3	C0238198
Disease	L2 Acute Lymphoblastic Leukemia	PAG1 KMT2A PRDM14	6.19e-03	50	220	3	C0023453
Disease	idiopathic scoliosis (implicated_via_orthology)	KIF6 DNAH10	6.20e-03	16	220	2	DOID:0060250 (implicated_via_orthology)
Disease	lysosomal storage disease (implicated_via_orthology)	TFEC GGA1	6.20e-03	16	220	2	DOID:3211 (implicated_via_orthology)
Disease	2-hydroxyglutarate measurement	ZFP91 PCNT	6.20e-03	16	220	2	EFO_0021506
Disease	Dyskeratosis Congenita	ACD WRAP53	6.20e-03	16	220	2	C0265965
Disease	aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement	SNX19 KCNU1 UBN1 ACAN UNC79 DNAH10 MACF1 SENP7	6.23e-03	364	220	8	EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946
Disease	disease recurrence, colon carcinoma	ANAPC2 KIF6 MACF1	6.54e-03	51	220	3	EFO_0004952, EFO_1001950
Disease	severe acute respiratory syndrome, COVID-19	MAGI1 FRMPD4 LYST MARCHF1 SLC23A2 ARHGEF18 MICALL1 ELP2 PDZD2	6.65e-03	447	220	9	EFO_0000694, MONDO_0100096
Disease	Intellectual Disability	FRMPD4 CACNA1G WDR62 ATN1 SHANK2 ZNF335 MACF1 ELP2 ZBTB11	6.65e-03	447	220	9	C3714756
Disease	Colorectal Carcinoma	ABCA3 ACACA BRAF GLI3 ABCG2 TBX22 TFEC FN1 TCOF1 CBFA2T3 PEX5L B4GALNT2	6.73e-03	702	220	12	C0009402
Disease	Schizophrenia	MAGI1 PAG1 PSD GABRQ CMYA5 MET SETDB1 PTPRZ1 KMT2A PML DRD1 TSNARE1 RGS12 PCNT	6.76e-03	883	220	14	C0036341
Disease	Squamous cell carcinoma of the head and neck	TSC2 MET ABCG2	6.91e-03	52	220	3	C1168401
Disease	Childhood Acute Lymphoblastic Leukemia	PAG1 KMT2A PRDM14	6.91e-03	52	220	3	C0023452
Disease	cerebellar volume measurement	ATP6AP1L ABCG2 PAX3	6.91e-03	52	220	3	EFO_0020864
Disease	Benign neoplasm of stomach	MET BRAF	6.99e-03	17	220	2	C0153943
Disease	Neoplasm of uncertain or unknown behavior of stomach	MET BRAF	6.99e-03	17	220	2	C0496905
Disease	Carcinoma in situ of stomach	MET BRAF	6.99e-03	17	220	2	C0154060
Disease	urate measurement, bone density	SNX19 SALL1 MARCHF1 SLC23A2 FAM135A FAM234B KIF6 FRAS1 CARMIL1 ROBO1 PDZD2	7.07e-03	619	220	11	EFO_0003923, EFO_0004531
Disease	health literacy measurement	PAG1 GLI3 GGA1	7.28e-03	53	220	3	EFO_0010104

Protein segments in the cluster

Peptide	Gene	Start	Entry
LTLLAESSNPATLEG	PKP4	831	Q99569
LQSSPSLDDDSLGSA	USH1G	346	Q495M9
LKETPGTLSSDTNDS	TACC1	291	O75410
LDINGSSDSSTLPKL	TDRD5	831	Q8NAT2
DRSSESTLGPQALEL	LINC01547	96	P58512
SSDEEPLSQVLSGSS	EPC1	376	Q9H2F5
PLSQVLSGSSEAEED	EPC1	381	Q9H2F5
STEGAVLPSSSDALL	EPG5	1871	Q9HCE0
PQEEASLAETALTSG	BRAF	301	P15056
LKLSDSDIPGSSEES	ARHGEF18	951	Q6ZSZ5
ASPSLGSLELQDLTT	CCDC187	776	A0A096LP49
LSKTDPASLETGQDS	ANAPC2	456	Q9UJX6
GSLEDPQTDSSVSLL	CTF1	6	Q16619
EAGVLPLLLSASTDS	CRYBG3	276	Q68DQ2
ASLGTLNTLADVPDS	B4GALNT2	231	Q8NHY0
SLGNLDISVSSSENP	ALPK2	176	Q86TB3
GEEDSQALSNVPSLS	ALPK2	1201	Q86TB3
SPETLESILESNGLS	COQ3	286	Q9NZJ6
IEDILNLESSPTASG	FERMT1	161	Q9BQL6
SPSDLDSLDGRSLND	ATN1	101	P54259
EPTTGLDSSTANAVL	ABCG2	211	Q9UNQ0
PSSSLEVSSANAEEL	AKAP13	1616	Q12802
VPNATLESSAGAELS	ABCA3	781	Q99758
SDTLSDLGISSLQDG	ACACA	56	Q13085
LLEQLLSTSDSPGDE	BIRC3	341	Q13489
SQEPASALATEDTSL	AGGF1	171	Q8N302
DDLPTGTEATLSSAV	ARID1B	756	Q8NFD5
PSDGNATSLAETIDN	DRD1	171	P21728
DGRESLPSTVSANSL	ACAP2	571	Q15057
DSLLHPGNLTSTSDD	ANO4	76	Q32M45
PGNLTSTSDDASRLE	ANO4	81	Q32M45
DASDTSLLGVLPASE	CD163L1	1436	Q9NR16
LGLSLTDELSNLPST	CHMP2A	171	O43633
LLPSEELLTDTSNSS	GRAMD1A	336	Q96CP6
LDGDSLQPEASESSA	CHM	616	P24386
TENSSLSSITLLDPG	OSMR	961	Q99650
ESSSPSVTEGQTLDL	HSPG2	2056	P98160
LSIGSLLDISNTPES	ECT2	411	Q9H8V3
LGSLESLANSETSDL	PCDHGA11	676	Q9Y5H2
GSLESPANSETSDLT	PCDHGA12	676	O60330
PDIQSSAATDGTSDL	PKIB	31	Q9C010
PNDEDTGDTSTSSLL	PCDH18	991	Q9HCL0
LGASDDPAELSTQLS	RADIL	46	Q96JH8
TSEEPTGFSVDSNLL	ARHGEF17	746	Q96PE2
LLESSRSQELSGPAS	ANKRD13A	496	Q8IZ07
LNTDASSVTGLSETP	MUC16	2121	Q8WXI7
SDITLGASPDVTNTL	MUC16	3436	Q8WXI7
DALASISIPGSETTD	MUC16	4576	Q8WXI7
GPSESTLESTLNLNT	MUC16	7626	Q8WXI7
NDETNAASLTPLGSS	NREP	41	Q16612
QEALSASGVSPSDLS	OSGEPL1	96	Q9H4B0
SGPEDTRAASSLNLS	MAP4K4	791	O95819
LQLSATDQDSGPTEL	FRAS1	2221	Q86XX4
SSEASQSDGLPSLLS	GLI3	906	P10071
ASPTDGTDLEASLLS	LIN52	6	Q52LA3
VVASLPLDQSDEGSS	MAGEA10	96	P43363
IPGDESSNATLLTNA	MAGI1	1091	Q96QZ7
EDSTLALAVGSESPL	KIAA1671	446	Q9BY89
ASDTDSSLEASAGPL	MAPK10	446	P53779
VSQAGSLSPAASLEE	NEUROG3	176	Q9Y4Z2
ALIGDESSAPDSQRS	GPANK1	46	O95872
SGPASTDAVSALLEQ	WWC1	806	Q8IX03
SRSPSQGDEDSALIL	MTMR7	591	Q9Y216
SSTGEDTALSELAIP	LRIT2	301	A6NDA9
ATESEHSLSPADLGS	NAB1	166	Q13506
PSLEEDSASLSGESL	NAB2	406	Q15742
PESLGSLTSTSEQAQ	GABRQ	411	Q9UN88
TGESLSDLPSTSEQA	GABRQ	446	Q9UN88
QEDPADTASVSSLSL	FAM91A1	356	Q658Y4
ASQSSSEIEVPLLGS	CDKN2AIP	281	Q9NXV6
SLTSINSLPSDDELS	FAM135A	836	Q9P2D6
TDAESETGIPKSLSN	PCYT1B	6	Q9Y5K3
LTVSATDEDGPLNSD	FAT2	3341	Q9NYQ8
SAPLLGSSVDLEESI	PDZD2	1031	O15018
ESSQEPSLLEGADSV	PDZD2	1371	O15018
TSRNLPATDEGDIIS	PDZD2	2286	O15018
TTGLDLLDLSEPVSQ	PEX5L	106	Q8IYB4
LSAASPNSDIILGTE	FAM234B	501	A2RU67
LRLEETASSSQDGDP	DDIAS	396	Q8IXT1
RTDLANGSLSSSPEE	DCAF8	11	Q5TAQ9
DGPLQESSTRLSLTS	FKBP15	1086	Q5T1M5
ESSTRLSLTSDPEEG	FKBP15	1091	Q5T1M5
SSIPLTGDSQTDSDI	KIF6	781	Q6ZMV9
SLSEVSEAGASNPSL	MACF1	151	O94854
TIESEAPSDSSGINL	LRRC37B	776	Q96QE4
SESASQTAGAELLEP	MICALL1	516	Q8N3F8
QTSLPASSGLDDLDL	GGA1	411	Q9UJY5
TLTIGSLQIDSSSDP	KCNU1	821	A8MYU2
ELDSLALNQSTGLPT	TWNK	266	Q96RR1
LLPDTDGLTALNISS	PTPRZ1	1006	P23471
EQLLLDASASSPIDS	CBFA2T3	266	O75081
RTPLGASLDEQSSST	ITPRID2	86	P28290
VTSLGEDLATPTAQD	ITPRID2	546	P28290
ETPSGDDFSLSLADT	C17orf75	66	Q9HAS0
ADTSLGDRADTSLPQ	PCNT	2256	O95613
SLTSAASPEDGLSAE	GORASP1	391	Q9BQQ3
SDPDTSSPSDDQLSL	LIX1	261	Q8N485
TPEISGDLADASQTS	MARCHF1	21	Q8TCQ1
ETSASGVEDLSRLPS	ACAN	1516	P16112
LEEADSSTGSPTSID	POU3F4	256	P49335
ILSERASAPQSDEGS	PAX3	191	P23760
ALDDGTPALSSSQTL	DCHS2	1696	Q6V1P9
ASSTDSLDTLSNGPE	NEFH	71	P12036
ESAPVGATISDSLNL	PCDH15	406	Q96QU1
QGSDLDSSATPINTV	EEA1	16	Q15075
PDGLVTDSSAELQSL	EEA1	126	Q15075
SPDADRVDSTTLLGN	FAM118A	311	Q9NWS6
EPAGTISQLSDTDLD	HYDIN	2711	Q4G0P3
LLTSQAQDTSGSPSE	BCL6B	276	Q8N143
LISGDSSSEPTLLLS	COL28A1	201	Q2UY09
ESILSGKENSSALSP	E2F8	651	A0AVK6
DVLSLSGLSSDPADL	CACNA1G	2361	O43497
PLTGDATTELSQDSK	COL12A1	986	Q99715
LQSLGEELSSVSPSE	CCDC18	36	Q5T9S5
DSQSLDIPNTADSLG	GJA9	461	P57773
GSSTELNLPETANSV	FN1	851	P02751
LNLSGSSDDIIDLTS	FRMPD4	771	Q14CM0
TSFLTISNEGSEESP	FAM117B	416	Q6P1L5
DGLQLTPASSSSESL	POLQ	1811	O75417
SISLEPDLDNSGSNT	CMYA5	266	Q8N3K9
TASSSPELENLASGL	CMYA5	1566	Q8N3K9
LSSESTPEDVLSQGK	CMYA5	3441	Q8N3K9
SHLNSESSIPEELGS	CEP350	1936	Q5VT06
SLQSGSIPLANESLE	DENND4C	1556	Q5VZ89
LEEDSPSSSSAGLDK	FOSL2	226	P15408
GDQSSDSLNSPTLLA	FOSL2	311	P15408
HDSDSLEPLNLSSGS	ELK3	266	P41970
TSLELTGNSIASIPD	ECM2	346	O94769
SSEITSVDLASGAPA	ATF7IP	231	Q6VMQ6
QGSNTDILSEPAALS	LYST	231	Q99698
SSNASLEVLSTEPGS	FSIP1	26	Q8NA03
SGSDRNSAILSDPSV	KMT2A	181	Q03164
QALGESPESSSSELL	KMT2A	2861	Q03164
SLDISDNGLESDLST	CARMIL1	486	Q5VZK9
LEELTSANDGRTLSP	DALRD3	196	Q5D0E6
ASVETPLNSVLGDSS	ENAH	271	Q8N8S7
SQPSDEEELLTSTGF	ELP2	516	Q6IA86
QDLGLSSSEDESPSL	CCDC201	6	A0A1B0GTI1
APQGSDSSDSELELS	KCNIP3	56	Q9Y2W7
ISDDELLSILGSSDP	DNAH10	1571	Q8IVF4
LPNIGTTAEDLNSLS	SALL1	406	Q9NSC2
GAISESSQLNLLPTE	PKD1L1	961	Q8TDX9
NATILERSLDPDSGT	COL5A3	316	P25940
STRELQTSSAGLEEP	ECSIT	396	Q9BQ95
ASLSSDSDGLLEVQP	FOCAD	976	Q5VW36
LTDTPDTTANAEGDL	DHX9	91	Q08211
SSDSIGPDVTDILSD	MED1	771	Q15648
RSQAPLESSLDSLGD	NUMA1	1781	Q14980
AVQLNGSSSLTSEDP	HSF2	326	Q03933
GSLDSPVDISADSLD	HOXA2	346	O43364
SVQIDLNSLTSEGPS	MINAR1	641	Q9UPX6
LNSLTSEGPSDDSAS	MINAR1	646	Q9UPX6
EADAGSLLPTTNELS	PHACTR3	191	Q96KR7
LATTSDDDLPGDLQS	FOXN4	31	Q96NZ1
TSGDSDISSPLLQNT	MET	1036	P08581
LSELDPLSTSGAELQ	PLEKHM1	201	Q9Y4G2
AEVSLSQTSLDPGQS	RUNDC3B	396	Q96NL0
SLLISDTQPEDLNSG	SENP7	256	Q9BQF6
LESSSPSLTDSLNGN	THADA	371	Q6YHU6
DLSPSEAESQLGLST	AHCYL2	21	Q96HN2
TPESENLTLSSSGAI	RNF157	476	Q96PX1
NTSLPAEEANGSLSE	WRAP53	101	Q9BUR4
DAPAASGTSESEALI	PRUNE2	1266	Q8WUY3
PLSQLVSDSDSELDS	PSD	521	A5PKW4
DSSGSDSLPQTLDKD	PRDM14	231	Q9GZV8
SDELLSGSVLSSPNS	PTBP2	16	Q9UKA9
ELAEQGEPDSSTLSL	SVIL	801	O95425
PSSTSSTLLGEDAEV	SYNJ1	991	O43426
SEDDVVAPSQSLLSG	TCOF1	1191	Q13428
DSLDSLDIPSSASDG	AATK	901	Q6ZMQ8
PETITSAGSSLLDSN	NHS	1231	Q6T4R5
IDITLSSSLSQAGDP	NCOA7	556	Q8NI08
TEQLILDGSTSSDPD	PKDREJ	351	Q9NTG1
DDSSSESSDLQLEGP	PML	576	P29590
SSSLSNVLEDGSLPE	NBEAL2	1406	Q6ZNJ1
SSLESATDEAGSPLA	NBEAL2	1636	Q6ZNJ1
LASSQEEDSGQSLPT	NEO1	1336	Q92859
SASDLLDSQDSTGKP	PAG1	111	Q9NWQ8
TPSERSLLSTGDENS	MRTFA	456	Q969V6
LNLNDASSSGPTDLS	NOL4	566	O94818
LSLALPSSETDLTQG	POM121L2	386	Q96KW2
TSASDDLEALGTLSL	NCKIPSD	281	Q9NZQ3
LSSKEVDPSTGELQS	SQSTM1	341	Q13501
SLSSLGEDQDSVLTP	ROBO4	781	Q8WZ75
PDDVLTLSSSTESEG	SETDB1	1096	Q15047
TGETPLTLAAQLDDS	SHANK2	196	Q9UPX8
SSEESGTSISLLPAL	ACD	286	Q96AP0
GSSAAPNLEELSRLT	CLCA2	446	Q9UQC9
SDINTIPGELTDASA	UFSP2	66	Q9NUQ7
SGNLEINPSTEITSL	TMPRSS11D	146	O60235
VEGETLPSSSTTLDN	ZNF451	566	Q9Y4E5
LSKENVISSSPEDSG	ZBTB11	441	O95625
STDRSQEGAPSTLLA	TTBK1	796	Q5TCY1
TSLERSLQSLGTPSD	TSNARE1	276	Q96NA8
SDPDDFTGLETSSLL	UNC80	3201	Q8N2C7
GSIELPSTSSNLESD	RGS12	236	O14924
RPSSGISEALISENE	SYNPO2	86	Q9UMS6
ATSDIITASSPNDGL	MUC13	116	Q9H3R2
PGSSLSSSIENLESE	SPEG	2316	Q15772
SLAETLDSTGSLDPQ	SLC23A2	71	Q9UGH3
SSLDSLDGLSLTDES	PSD2	156	Q9BQI7
NSASDPSLKDGLSDS	PSD2	271	Q9BQI7
PSLKDGLSDSDSELS	PSD2	276	Q9BQI7
SSVDLSQIQSLPTEG	TBX22	231	Q9Y458
NASDTGAPTQLLTES	SP2	221	Q02086
DSSPLLNEVSSSLIG	SORBS1	271	Q9BX66
PLGSSDSVISQLSDA	SORBS1	1096	Q9BX66
SEGDANESSLLVLSS	TXNDC2	31	Q86VQ3
VSTRNLLSDSEPSGE	FAM170A	176	A1A519
TEQQGALSSELPSTS	USP25	491	Q9UHP3
SPETAQLRASDGSLL	UAP1L1	311	Q3KQV9
PNTDGISSLENLLAS	RXFP1	391	Q9HBX9
NSSLEPADLSEPNST	SERPINE3	136	A8MV23
SGRSLSQEDLPSEAS	ARHGAP9	161	Q9BRR9
VLGSSVDQLSAESPD	TECPR2	511	O15040
INPSSSLKAELDGST	TSTD2	31	Q5T7W7
SELSGSINDLNTLDP	RFX7	1291	Q2KHR2
LEQTPASSVGDLESS	ROBO1	1351	Q9Y6N7
NSDPGTETELADTAL	SNX19	811	Q92543
EDLPLTLESAASSQT	TRBV10-1	91	A0A0K0K1A3
PGADVVDLTLDSSSS	PIAS4	461	Q8N2W9
DAPSISTLGLQQETT	ZDHHC11	386	Q9H8X9
SLASLLSESESPQEA	WDR62	906	O43379
SLDDSVVGPSALLSS	XNDC1N	156	Q6ZNB5
EEDFTLDVSLSPSSG	ZBED6	196	P86452
ESSALPSGQLTSLSE	TRAP1	471	Q12931
SDPLLSLFGSTSDND	UBN1	286	Q9NPG3
PLSEQDSVLTTNSSG	ZNF236	1456	Q9UL36
TTLDSDAGLTENPLT	TFEC	31	O14948
TSTDILGTNPESLTQ	ZFP91	471	Q96JP5
DTGDSTDLQLVPLNT	TRAPPC10	981	P48553
QEADDAPSTSTLGLQ	ZDHHC11B	341	P0C7U3
SSENAGTSDLELPVS	ARHGAP21	696	Q5T5U3
LAQGPDAATTDELSS	TBC1D10A	26	Q9BXI6
AAIEALADGPTSTST	ZNF335	191	Q9H4Z2
AGSDSTSLVDSELSP	UHRF1BP1	896	Q6BDS2
QALLLPSDTDDGSSL	ATP6AP1L	101	Q52LC2
DRGSNPSLESTSSEL	ZFYVE26	781	Q68DK2
ILGQLDSSSLALPSE	PKP2	21	Q99959
PLSLKSDTTDSSQGL	ZFC3H1	326	O60293
LPSVDIDSISNSSAD	KIAA0586	801	Q9BVV6
SSSPELQTLQDILGD	TSC2	1386	P49815
DLIDLSSDSTSGPEK	UNC79	1606	Q9P2D8
SAGNTDSALITLEDP	UNC79	1706	Q9P2D8
SELTFSLSPDDLGTS	VPS13D	1506	Q5THJ4
SASLAGTSNLSETEP	LEG1	16	Q6P5S2
ETTLLPDNTTASGLL	MUC12	731	Q9UKN1
LTPASSTSAGLQEES	MUC12	1566	Q9UKN1
ETTLLPDNTTASGLL	MUC12	1786	Q9UKN1
LLPDNTTASGLLEAS	MUC12	3346	Q9UKN1
ETTLLPDNTTASGLL	MUC12	4426	Q9UKN1
TPDSESSQGSLELLS	MYO9A	1321	B2RTY4
TPGLSQSLALSSDES	PPP1R9A	946	Q9ULJ8